{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":373,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":373,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"85fc674c8bb3","filters":{"venue":"Breast Cancer Research"}},"results":[{"id":"W2571423414","doi":"10.1186/s13058-016-0794-1","title":"Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":693,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Hazard ratio; Breast cancer; Confidence interval; Oncology; Cutoff; Neutrophil to lymphocyte ratio; Surgical oncology; Stage (stratigraphy); Cancer; Lymphocyte; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1665139501609582,"gpt":0.4678208927142328,"spread":0.3013069425532746,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003916542,0.0008276257,0.01296162,0.002242517,0.0002094862,0.0001456308,0.001098774,0.0003627626,0.001008744],"category_scores_gemma":[0.0004692139,0.0005718423,0.002486486,0.003132839,0.000437931,0.0001578249,0.000622704,0.0008240914,0.00005561226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001299593,"about_ca_system_score_gemma":0.004113962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002931986,"about_ca_topic_score_gemma":0.0004021119,"domain_scores_codex":[0.9916782,0.00194016,0.002179754,0.00132052,0.001887172,0.0009942246],"domain_scores_gemma":[0.9938345,0.0004554174,0.001140691,0.002401179,0.001451524,0.0007167223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001353933,0.0001424875,0.0008893727,0.8700516,0.1021455,0.0001172763,0.00003799109,8.50512e-7,0.000001181189,0.00001724801,0.0002252992,0.02623579],"study_design_scores_gemma":[0.0003964753,0.00003623296,0.002147436,0.2623734,0.726386,0.0004016035,0.00001901929,0.00001840248,9.1599e-7,0.000005657906,0.007765001,0.0004498376],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001776054,0.9809431,6.371551e-7,0.001663357,0.00003303709,0.01381317,0.003359576,0.00003128173,0.0001380582],"genre_scores_gemma":[0.0006792405,0.9732565,0.00003116464,0.0001409403,0.0001167846,0.02515074,0.00007774607,0.0001286678,0.0004181711],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6242405,"threshold_uncertainty_score":0.9999045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163060364","doi":"10.1186/bcr2942","title":"Mammographic density and breast cancer risk: current understanding and future prospects","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":618,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Ontario Ministry of Health and Long-Term Care; Canadian Breast Cancer Research Alliance","keywords":"Breast cancer; Medicine; Surgical oncology; Context (archaeology); Oncology; Disease; Cancer; Gynecology; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1197132135018591,"gpt":0.4066424522613251,"spread":0.2869292387594661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009865859,0.0006988659,0.001703233,0.001443773,0.0005227259,0.0003028045,0.0002728024,0.0003338504,0.0001976888],"category_scores_gemma":[0.00001766723,0.0005215358,0.0004408913,0.002107642,0.001018965,0.0003214719,0.0003635812,0.002445037,0.000009248993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006520799,"about_ca_system_score_gemma":0.001059563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001627974,"about_ca_topic_score_gemma":0.0003161423,"domain_scores_codex":[0.9958342,0.0003055097,0.0005045439,0.001238254,0.0009358153,0.001181691],"domain_scores_gemma":[0.9977524,0.0001427852,0.0002614238,0.0005899806,0.0003924198,0.0008609772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002271288,0.0001385129,0.02768572,0.02091436,0.0005235884,0.00007467899,0.0001216092,6.92131e-9,3.039182e-7,0.00122006,0.000790017,0.948304],"study_design_scores_gemma":[0.001743756,0.000154252,0.1088103,0.06414769,0.002653258,0.0129295,0.0003801218,0.000005418824,8.022149e-7,0.001311751,0.8066708,0.001192314],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007069201,0.993947,0.00000766039,0.0006485079,0.0004361751,0.001758644,0.00145874,0.00009320476,0.0009430983],"genre_scores_gemma":[0.006764676,0.990511,0.00001810553,0.0000189801,0.00199822,0.0004096977,0.00004524614,0.0001257863,0.0001082775],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9471117,"threshold_uncertainty_score":0.9998564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107380545","doi":"10.1186/bcr3148","title":"CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":433,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Centre for Advancing Health Outcomes; McGill University; University of British Columbia","funders":"Michael Smith Health Research BC; Canadian Breast Cancer Research Alliance; Susan G. Komen; National Cancer Institute; Sanofi","keywords":"Surgical oncology; Breast cancer; Infiltration (HVAC); Medicine; Basal (medicine); Tumor-infiltrating lymphocytes; Oncology; Pathology; CD8; Internal medicine; Cancer; Immunology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.05920947704377097,"gpt":0.3825326707427997,"spread":0.3233231936990287,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001784508,0.0002892875,0.0003938082,0.000670304,0.0002579683,0.0001074462,0.000320196,0.0002613897,0.005571498],"category_scores_gemma":[0.0000245017,0.00025215,0.0001045391,0.001333955,0.0002822335,0.0007146994,0.0001049158,0.0006743948,0.0001225085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002454261,"about_ca_system_score_gemma":0.002706323,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03917663,"about_ca_topic_score_gemma":0.004424493,"domain_scores_codex":[0.9957806,0.0003054575,0.00047581,0.0005864107,0.001517652,0.001334033],"domain_scores_gemma":[0.9982852,0.00008670537,0.0001176417,0.0005853867,0.000343904,0.0005811647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006264034,0.0008553491,0.8789929,0.0002776686,0.0001730235,0.00002551684,0.001969195,0.000006359108,0.02170517,0.00002850636,0.004215231,0.08548708],"study_design_scores_gemma":[0.004378013,0.0001648139,0.981445,0.000583797,0.00004172529,0.0003144916,0.0005677915,0.000127505,0.004610254,0.00001814962,0.007442149,0.0003062907],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861757,0.004916644,0.000009432562,0.005588933,0.0004842187,0.001440185,0.0004909307,0.00007090472,0.0008231037],"genre_scores_gemma":[0.9930611,0.002670761,0.00003650512,0.001234034,0.0009581112,0.001043916,0.00005780182,0.0000756007,0.0008622082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1024521,"threshold_uncertainty_score":0.9999931,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046194218","doi":"10.1186/bcr1831","title":"Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence","year":2008,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":372,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"Hospital for Sick Children","keywords":"Breast cancer; MAMMOGRAPHIC DENSITY; Risk factors for breast cancer; Biology; Medicine; Physiology; Oncology; Mammography; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1088811489775876,"gpt":0.3853329051467475,"spread":0.2764517561691598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003240196,0.001349244,0.004665392,0.003592514,0.0006059388,0.0001418588,0.001038514,0.0009432891,0.0003574874],"category_scores_gemma":[0.0009112371,0.0009108912,0.002381032,0.00714108,0.002314751,0.0003251092,0.000292564,0.003625418,0.00002498534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007160273,"about_ca_system_score_gemma":0.003080873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005105506,"about_ca_topic_score_gemma":0.0004760363,"domain_scores_codex":[0.987926,0.002793035,0.001430772,0.002057525,0.003679388,0.002113265],"domain_scores_gemma":[0.9911518,0.003027365,0.001171862,0.001503036,0.002151978,0.0009939858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00408748,0.001600235,0.05732169,0.008546783,0.003301824,0.001980668,0.00001968716,0.00006946641,0.00002571317,0.0001429334,0.001179584,0.921724],"study_design_scores_gemma":[0.004925375,0.003072709,0.5882062,0.3637798,0.008645847,0.01770865,0.00009219506,0.0006577456,0.00005343903,0.001139541,0.008390801,0.003327685],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008214124,0.9813557,0.0004705685,0.001303654,0.0003006959,0.003661552,0.00409822,0.0003044092,0.000291074],"genre_scores_gemma":[0.2154273,0.7828113,0.000122346,0.0001870801,0.0003549157,0.0006714679,0.0001272414,0.0001908456,0.0001074215],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9183962,"threshold_uncertainty_score":0.9999259,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009098155","doi":"10.1186/bcr3072","title":"Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Victoria; BC Cancer Agency","funders":"BC Cancer Agency; Canadian Institutes of Health Research; Office of Defense Programs; BC Cancer Foundation; U.S. Department of Defense","keywords":"Anthracycline; Surgical oncology; Breast cancer; Medicine; Oncology; Estrogen receptor; Chemotherapy; Internal medicine; Cancer; Estrogen; Cancer research; Tumor-infiltrating lymphocytes; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.05764511822765091,"gpt":0.3779465774786152,"spread":0.3203014592509643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002460524,0.0003891151,0.0005746893,0.0007645074,0.0002387366,0.00006447222,0.0004498948,0.0001668306,0.006371752],"category_scores_gemma":[0.0001595135,0.0003387023,0.0001872037,0.002088079,0.0005093108,0.0002036337,0.0000846028,0.0006237936,0.00005427658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002329575,"about_ca_system_score_gemma":0.003841337,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04551506,"about_ca_topic_score_gemma":0.001570723,"domain_scores_codex":[0.9955441,0.0006137429,0.0006373645,0.0008489032,0.001169127,0.001186709],"domain_scores_gemma":[0.9976208,0.0004042673,0.0001416527,0.0006720932,0.000677012,0.0004841512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.29739,0.0009125834,0.3049654,0.0002169175,0.0003498715,0.0001724891,0.003965502,0.00003465619,0.2455667,0.00001244891,0.004263952,0.1421495],"study_design_scores_gemma":[0.01181146,0.0006891792,0.8383443,0.001853833,0.00002388167,0.0002085776,0.001159835,0.0002821639,0.1430161,0.00002126329,0.002160016,0.0004293923],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835122,0.0008639227,0.00001648537,0.01223573,0.0002183632,0.001644206,0.0008642018,0.0001119221,0.000532951],"genre_scores_gemma":[0.9945524,0.0004891068,0.0007358937,0.001858734,0.0005204137,0.001276196,0.00001469372,0.0001153803,0.0004371954],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5333788,"threshold_uncertainty_score":0.9999065,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896306379","doi":"10.1186/s13058-018-1051-6","title":"Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Overweight; Aerobic exercise; Physical therapy; Quality of life (healthcare); Randomized controlled trial; Physical fitness; Internal medicine; Physical strength; Obesity; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04270215889316004,"gpt":0.401488321792388,"spread":0.3587861628992279,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003614514,0.0002955102,0.002898637,0.0003094293,0.0001810243,0.00006485191,0.0001048487,0.000136465,0.0001162551],"category_scores_gemma":[0.0003786335,0.0002107168,0.0001604031,0.0005374054,0.001850949,0.0001734229,0.0001488674,0.0004994526,8.730188e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002386387,"about_ca_system_score_gemma":0.001597311,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1205172,"about_ca_topic_score_gemma":0.05079625,"domain_scores_codex":[0.9959077,0.0008840585,0.0009373652,0.0006951397,0.0008983196,0.000677408],"domain_scores_gemma":[0.9972531,0.0008565264,0.0003281382,0.0003782621,0.0005549406,0.00062906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9699808,0.0003897254,0.01546777,0.00112497,0.0001527017,0.000004138308,0.001815455,1.180856e-7,0.001434207,0.0003073323,0.0003699566,0.00895281],"study_design_scores_gemma":[0.8579069,0.000329441,0.1388304,0.00146574,0.0000782628,0.00001174065,0.0003961563,0.0001502489,0.00007249348,0.0003533926,0.0001634698,0.000241744],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.965476,0.02349819,0.000002702347,0.005846854,0.0001567984,0.0045887,0.000282532,0.00001989149,0.0001282773],"genre_scores_gemma":[0.978404,0.01877897,0.00002255415,0.0001297219,0.0007930457,0.001299168,0.000006790534,0.00003715531,0.0005285488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1233626,"threshold_uncertainty_score":0.9665242,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116443943","doi":"10.1186/s13058-014-0442-6","title":"The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"Breast Cancer Campaign; Goddard Space Flight Center; National Institute for Health and Care Research","keywords":"Surgical oncology; Medicine; Cancer; Breast cancer; Family medicine; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01078677033509385,"gpt":0.351908186291988,"spread":0.3411214159568942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001178148,0.0002214804,0.0002231964,0.00009949991,0.0003680483,0.0000893854,0.000553794,0.0002106747,0.00009829379],"category_scores_gemma":[0.00005812227,0.0001434501,0.0001168676,0.0003340492,0.0002510708,0.000007695273,0.0002362261,0.0003851177,0.00000958234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004533684,"about_ca_system_score_gemma":0.0008025789,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01196392,"about_ca_topic_score_gemma":0.007438026,"domain_scores_codex":[0.9974561,0.0005382111,0.0002131774,0.0005384191,0.000656595,0.0005974911],"domain_scores_gemma":[0.9981861,0.000120111,0.0001425108,0.0007505044,0.000658646,0.0001421168],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004870554,0.000373336,0.1024035,0.001011889,0.00100482,0.000007629442,0.0008877733,0.001076908,0.5680483,0.0001946119,0.0270687,0.293052],"study_design_scores_gemma":[0.002611997,0.001781853,0.3123029,0.0003616572,0.0000737527,0.0000262451,0.0001975701,0.001557347,0.66403,0.0002465621,0.01635985,0.0004501823],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916265,0.001810926,0.000003773582,0.004386774,0.0001984439,0.0008851272,0.0005701493,0.00001941291,0.0004988702],"genre_scores_gemma":[0.9969562,0.0004758211,0.00003852793,0.00005803088,0.000452093,0.0007793998,0.00008761072,0.00005157313,0.001100708],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2926018,"threshold_uncertainty_score":0.9946155,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1945350395","doi":"10.1186/bcr658","title":"A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":317,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"Medical Research and Materiel Command; Hôpitaux Universitaires de Genève; Susan G. Komen; Breast Cancer Research Foundation","keywords":"Breast cancer; Medicine; Hazard ratio; Oncology; Internal medicine; Surgical oncology; Germline mutation; BRCA mutation; Confidence interval; Cancer; Germline; BRCA2 Protein; Proportional hazards model; Gynecology; Mutation; Genetics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05285228927728674,"gpt":0.3886168014027394,"spread":0.3357645121254527,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005196484,0.0001631715,0.0003988771,0.0004509306,0.00006711488,0.00002144686,0.0001121092,0.0001035053,0.00009642508],"category_scores_gemma":[0.00005678122,0.000146023,0.0001278155,0.0009609259,0.0001470551,0.000008584047,0.00002499654,0.00009507068,3.336375e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004092677,"about_ca_system_score_gemma":0.001050007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005425746,"about_ca_topic_score_gemma":0.007641876,"domain_scores_codex":[0.9979842,0.0003608916,0.0004021949,0.0004309129,0.0004897203,0.0003321252],"domain_scores_gemma":[0.9990979,0.00009549074,0.000136522,0.0003109188,0.0002643607,0.00009484399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001082354,0.0003344286,0.9696856,0.0000519555,0.0005444265,0.000005563778,0.0001865804,0.002685739,0.01611728,0.00009752562,0.000006709884,0.009201896],"study_design_scores_gemma":[0.002011568,0.0004134278,0.9749033,0.00005218008,0.0001758696,0.000002139901,0.0003873656,0.001935052,0.01992854,0.000019537,0.00003048415,0.0001405012],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976114,0.0005173308,0.00008018079,0.000397351,0.00009237314,0.000317971,0.0008266325,0.000003906661,0.0001528316],"genre_scores_gemma":[0.9990829,0.0003374711,0.00008263733,0.00001578246,0.00002523685,0.0002410988,0.0001295532,0.00001682532,0.00006851048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009061395,"threshold_uncertainty_score":0.8202142,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143940059","doi":"10.1186/bcr801","title":"The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":306,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institutes of Health; University of California, Irvine; University of Melbourne; Canadian Breast Cancer Research Alliance; National Center for Research Resources; Huntsman Cancer Foundation; Cancer Care Ontario","keywords":"Breast cancer; Medicine; Epidemiology; Family history; Family medicine; Cancer; Genetic epidemiology; Population; Epidemiology of cancer; Oncology; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.06305866834243463,"gpt":0.4426976325341854,"spread":0.3796389641917507,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007816307,0.0002131108,0.0003063408,0.00007091658,0.0005915202,0.00001482664,0.0005335753,0.0001672563,0.00002608313],"category_scores_gemma":[0.0001033508,0.0001366354,0.0001075118,0.0003280899,0.001985062,0.00001827455,0.0003076595,0.0002681273,1.902509e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002578839,"about_ca_system_score_gemma":0.002109718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001018321,"about_ca_topic_score_gemma":0.003529848,"domain_scores_codex":[0.997848,0.0003646195,0.0004747616,0.0005320723,0.0003652632,0.0004152677],"domain_scores_gemma":[0.9969937,0.0002536557,0.0002407344,0.0004618018,0.00196496,0.0000851021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00611501,0.0003959759,0.3425609,0.0008533579,0.002616051,0.000002028936,0.006215153,0.161789,0.2995751,0.003827553,0.01578858,0.1602613],"study_design_scores_gemma":[0.001452136,0.0001184769,0.9860212,0.0002140294,0.00005223261,0.0001230495,0.002032041,0.0003706517,0.004971613,0.003753065,0.0007019905,0.0001895388],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9444414,0.02070897,0.0003828393,0.02514455,0.0003402071,0.0009497422,0.007991901,0.000005887429,0.0000344697],"genre_scores_gemma":[0.9935947,0.003923795,0.0005570948,0.0001722732,0.000525238,0.001019755,0.0000448156,0.00003450416,0.0001278399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6434602,"threshold_uncertainty_score":0.7314045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116208747","doi":"10.1186/bcr622","title":"Mammographic density is related to stroma and stromal proteoglycan expression","year":2003,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Manitoba; McMaster University","funders":"","keywords":"Lumican; Decorin; Medicine; Breast cancer; Pathology; Stromal cell; Stroma; Biopsy; Mammography; Immunohistochemistry; Surgical oncology; Cancer; Proteoglycan; Oncology; Internal medicine; Anatomy","retraction":null,"screen_n_in":null,"score":{"opus":0.03761969320235316,"gpt":0.3625166082930517,"spread":0.3248969150906985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007033191,0.0001679908,0.0002604433,0.000375104,0.0002966656,0.00005004518,0.0001114873,0.00014427,0.001294637],"category_scores_gemma":[0.0000475115,0.0001367989,0.00006891588,0.0008897807,0.0001846396,0.00007879614,0.000125133,0.0006031365,0.00004369898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001304916,"about_ca_system_score_gemma":0.0003585556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008767744,"about_ca_topic_score_gemma":0.00005883528,"domain_scores_codex":[0.9975477,0.0002306478,0.0002088924,0.0005462359,0.0008128813,0.0006536281],"domain_scores_gemma":[0.9983962,0.0000345128,0.00002972461,0.0004803336,0.0003945052,0.0006646843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00149648,0.0003062457,0.7405909,0.0001929256,0.00008123639,0.0002514124,0.0006608837,0.000001051818,0.2251263,0.001311913,0.007801876,0.02217874],"study_design_scores_gemma":[0.001400182,0.0002863945,0.9789811,0.000347951,0.00002170655,0.0008664582,0.0003803729,0.00001366201,0.01445764,0.0002314083,0.002860542,0.0001525652],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918665,0.0004273591,0.00001449309,0.0046766,0.00005311569,0.0009336122,0.00005035099,0.00004636508,0.001931572],"genre_scores_gemma":[0.9966423,0.00005173684,0.0004509749,0.000181882,0.00006498159,0.0001942334,0.000004026566,0.00003553549,0.002374309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2383902,"threshold_uncertainty_score":0.9996183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013797830","doi":"10.1186/bcr2904","title":"Luminal-B breast cancer and novel therapeutic targets","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Surgical oncology; Estrogen receptor; Medicine; Cancer research; Gene expression profiling; Bioinformatics; Pathological; Endocrine system; Oncology; Cancer; Internal medicine; Gene; Gene expression; Biology; Hormone; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.289696687158721,"gpt":0.5148012716975511,"spread":0.2251045845388301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002817158,0.001052014,0.003056848,0.001449261,0.0004691933,0.0002151341,0.001184573,0.0009408694,0.009073609],"category_scores_gemma":[0.00007648634,0.0008072461,0.0005897849,0.002276122,0.001475065,0.0001951918,0.0009284308,0.004512765,0.00048948],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00279226,"about_ca_system_score_gemma":0.01039704,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01711143,"about_ca_topic_score_gemma":0.0008975865,"domain_scores_codex":[0.990891,0.0006373692,0.001041539,0.001999149,0.002738333,0.002692634],"domain_scores_gemma":[0.9944687,0.0004215472,0.0002763842,0.001703688,0.001651245,0.001478372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004041017,0.0003284155,0.0004892402,0.03598611,0.0008816942,0.0001506144,0.0001806792,8.316776e-8,0.00002438142,0.0003271879,0.01190914,0.9493183],"study_design_scores_gemma":[0.001178095,0.000166385,0.003242844,0.03280868,0.0007677325,0.004235284,0.00006832238,0.000008451707,0.000006369632,0.00005492904,0.9567365,0.0007264026],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001763823,0.9860907,0.00001059733,0.002468724,0.0006104808,0.003727945,0.003474423,0.0001178151,0.003481665],"genre_scores_gemma":[0.000220376,0.9806761,0.00005876616,0.0002041811,0.003490369,0.004708198,0.00010183,0.0004624577,0.01007777],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9485919,"threshold_uncertainty_score":0.9994379,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155901347","doi":"10.1186/s13058-014-0432-8","title":"Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; McGill University; University of British Columbia","funders":"Michael Smith Health Research BC; Susan G. Komen; National Cancer Institute; Sanofi","keywords":"Surgical oncology; Estrogen receptor; Cytotoxic T cell; Cancer research; Infiltration (HVAC); Epidermal growth factor receptor; Breast cancer; FOXP3; Medicine; Human Epidermal Growth Factor Receptor 2; Oncology; Receptor; Internal medicine; Biology; Cancer; Immunology; Immune system","retraction":null,"screen_n_in":null,"score":{"opus":0.03460279391486393,"gpt":0.3420828550460022,"spread":0.3074800611311382,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008209328,0.0003235639,0.0005234155,0.0003723671,0.000232343,0.00007657682,0.0001529458,0.0001409293,0.0005984727],"category_scores_gemma":[0.0001004268,0.0002761924,0.00007074315,0.0005150894,0.0004609878,0.0002323322,0.00008213867,0.0005005131,0.000003366896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006710453,"about_ca_system_score_gemma":0.0007381793,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009102108,"about_ca_topic_score_gemma":0.0003562716,"domain_scores_codex":[0.9965953,0.0004791295,0.0006089271,0.000688843,0.0008505957,0.0007772145],"domain_scores_gemma":[0.9983331,0.0004287952,0.0002501722,0.0002812831,0.0003791812,0.0003274631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002022079,0.0001739217,0.3957419,0.0005141456,0.00003097919,0.000002725181,0.0003330057,0.000004270833,0.5691425,0.00004786357,0.0002078551,0.03177876],"study_design_scores_gemma":[0.00510502,0.0006418852,0.6462978,0.00167297,0.00002066992,0.00004548104,0.0003008675,0.0001176052,0.3451626,0.00001690648,0.000325993,0.000292235],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952331,0.001920308,0.00001225249,0.0007392126,0.0001208563,0.001211784,0.0005431614,0.00003534332,0.0001840218],"genre_scores_gemma":[0.9973452,0.001468792,0.00009046787,0.00009710396,0.0002840725,0.0005570974,0.00005223806,0.00005354773,0.00005146661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2505559,"threshold_uncertainty_score":0.999969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025588037","doi":"10.1186/bcr2102","title":"Mammographic density. Measurement of mammographic density","year":2008,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"National Cancer Institute","keywords":"MAMMOGRAPHIC DENSITY; Breast density; Mammography; Breast cancer; Non-ionizing radiation; Medical physics; Medicine; Measure (data warehouse); Modalities; Ultrasound; Radiology; Cancer; Computer science; Data mining; Optics; Internal medicine; Physics","retraction":null,"screen_n_in":null,"score":{"opus":0.1448007083666609,"gpt":0.4089049189037251,"spread":0.2641042105370642,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002095956,0.0007863187,0.003086173,0.003985457,0.0003407703,0.00008708026,0.0007127918,0.0004792673,0.0001492854],"category_scores_gemma":[0.0001176815,0.0006365427,0.00232824,0.006392208,0.001434716,0.0001970843,0.0003900831,0.002068202,0.00006141209],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005326486,"about_ca_system_score_gemma":0.002804663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001702518,"about_ca_topic_score_gemma":0.0002043851,"domain_scores_codex":[0.9911588,0.0005814268,0.001135455,0.001180052,0.004350034,0.001594266],"domain_scores_gemma":[0.9945709,0.0001900919,0.0003915657,0.001415905,0.002670279,0.0007612611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002534564,0.0005414734,0.006048726,0.0227777,0.001441485,0.0005047796,0.00002699878,9.483187e-8,0.00001407117,0.0001187333,0.003216844,0.9650556],"study_design_scores_gemma":[0.001540281,0.000358973,0.02657363,0.08477142,0.001913201,0.01898112,0.00005374119,0.000002130817,0.0000476795,0.0001500317,0.8645188,0.001088941],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008785697,0.9936002,0.00001398913,0.0002556553,0.0002372805,0.001974917,0.0002813048,0.0001129491,0.002645174],"genre_scores_gemma":[0.01637387,0.9822342,0.00006383275,0.0000356424,0.0004976392,0.0003437539,0.00007688793,0.0001545581,0.0002195478],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9639667,"threshold_uncertainty_score":0.9996086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165023188","doi":"10.1186/bcr2919","title":"Rare variants in the ATMgene and risk of breast cancer","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":231,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute; Medical Research Council; U.S. Public Health Service; Cancer Australia; Norris Cotton Cancer Center; National Institutes of Health; Fox Chase Cancer Center; National Breast Cancer Foundation; Huntsman Cancer Institute; Georgetown University; National Health and Medical Research Council; Cancer Care Ontario","keywords":"Breast cancer; Surgical oncology; Medicine; Oncology; Internal medicine; Cancer; Bioinformatics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04870245419229828,"gpt":0.3567711079926521,"spread":0.3080686538003538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008779022,0.0001149659,0.0001266165,0.00009449186,0.0001100033,0.00001822144,0.0003960579,0.0001114481,0.0003886231],"category_scores_gemma":[0.000030002,0.00008623947,0.00003920397,0.0003849374,0.0003140494,0.000007225637,0.0001821486,0.0002443429,0.000003956184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008836724,"about_ca_system_score_gemma":0.0005649272,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01306046,"about_ca_topic_score_gemma":0.004794482,"domain_scores_codex":[0.9984344,0.0003364612,0.000185215,0.0003614161,0.0003310922,0.0003514327],"domain_scores_gemma":[0.9990883,0.00002924303,0.00006501943,0.0004507622,0.0003034467,0.00006320926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001230003,0.0002574619,0.7989853,0.0001125076,0.0002691165,0.00001625704,0.003009123,0.00009029452,0.0924279,0.0002120255,0.006844074,0.09654592],"study_design_scores_gemma":[0.0006322145,0.00005714067,0.9817813,0.00004784041,0.00002075979,0.0001018161,0.0005060146,0.00003074532,0.01496758,0.0001837615,0.001550028,0.0001207659],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927017,0.003830801,0.00002528533,0.0008144738,0.00009220545,0.0003066206,0.0009866937,0.000003575678,0.001238607],"genre_scores_gemma":[0.9933624,0.005667882,0.0001310542,0.00007051646,0.0002428649,0.0003172161,0.00001132606,0.00002213012,0.0001746512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.182796,"threshold_uncertainty_score":0.9935117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2066606787","doi":"10.1186/bcr3373","title":"Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":226,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Surgical oncology; Unfolded protein response; ATF4; Breast cancer; Hypoxia (environmental); Cancer research; Medicine; Internal medicine; Oncology; Cancer; Chemistry; Apoptosis; Biochemistry; Oxygen","retraction":null,"screen_n_in":null,"score":{"opus":0.01487392239615884,"gpt":0.3050089683791544,"spread":0.2901350459829956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004947478,0.000167071,0.0001763478,0.00005740186,0.0001714768,0.00003984482,0.0005553241,0.0001182397,0.0005291117],"category_scores_gemma":[0.00006468458,0.00009641144,0.0001459172,0.0003066591,0.0005259665,0.00001120818,0.0002586124,0.0002025146,0.000009393631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005196331,"about_ca_system_score_gemma":0.0005622229,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0119968,"about_ca_topic_score_gemma":0.0005976085,"domain_scores_codex":[0.997856,0.000526846,0.0002958389,0.0003366451,0.0005852523,0.0003994454],"domain_scores_gemma":[0.998219,0.00007471984,0.0001440216,0.0006952994,0.0007451049,0.0001218876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001467935,0.000141666,0.006172059,0.00008795012,0.0000638841,7.766446e-7,0.0001047674,0.0003681293,0.9839104,0.00002596228,0.003171051,0.004485365],"study_design_scores_gemma":[0.0007324022,0.0001041484,0.2388477,0.0001543102,0.00002442816,0.00001362981,0.000201751,0.0005884769,0.7582006,0.0001716066,0.0008164441,0.0001445394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928726,0.0009584876,0.00001456105,0.004405456,0.00006902372,0.001024011,0.0005288427,0.000005200623,0.0001218409],"genre_scores_gemma":[0.9980369,0.0002399175,0.00001909883,0.00006903086,0.0001514417,0.0005673427,0.00001182693,0.00002601806,0.0008784622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2326756,"threshold_uncertainty_score":0.9945824,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024847974","doi":"10.1186/bcr3210","title":"Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Digital mammography; Mammography; Radiology; Breast cancer; Concordance; Nuclear medicine; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.112413623572482,"gpt":0.4648473382621818,"spread":0.3524337146896998,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001826412,0.0002983653,0.0007209415,0.0007253216,0.0001406754,0.0001129158,0.000232965,0.000143986,0.00008533585],"category_scores_gemma":[0.000478174,0.0002465894,0.0004187285,0.001476447,0.00106185,0.000763486,0.0002047401,0.0007112261,0.00002603656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008600632,"about_ca_system_score_gemma":0.0003674793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002072507,"about_ca_topic_score_gemma":0.00008712535,"domain_scores_codex":[0.9953436,0.0003366663,0.00101554,0.0006067322,0.001460581,0.001236931],"domain_scores_gemma":[0.9965805,0.0007430532,0.0001686644,0.0006760156,0.0009021577,0.0009296545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01761561,0.01460222,0.3180395,0.0001249744,0.0008969855,0.0003001678,0.001137675,0.000002050109,0.001361874,0.0001571367,0.001751892,0.6440099],"study_design_scores_gemma":[0.02568631,0.002398088,0.9584744,0.0006030948,0.0002288394,0.0008983379,0.004714161,0.0001437347,0.003034328,0.00005871692,0.003221493,0.0005385175],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851795,0.0005451879,0.00008367749,0.0007935239,0.0003566156,0.0009432846,0.001102707,0.0001011341,0.01089441],"genre_scores_gemma":[0.9979137,0.00006939127,0.000069735,0.00008672288,0.001203673,0.0001793536,0.00006563441,0.00005700337,0.0003547427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6434714,"threshold_uncertainty_score":0.9999986,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105567212","doi":"10.1186/bcr3231","title":"Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Surgical oncology; Medicine; Breast cancer; Oncology; Cisplatin; Internal medicine; Chemotherapy; Metastatic breast cancer; Cancer; Randomized controlled trial; Open label","retraction":null,"screen_n_in":null,"score":{"opus":0.07042442315505405,"gpt":0.4650166770510589,"spread":0.3945922538960048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002566039,0.0002680739,0.001448701,0.0004747404,0.00009133147,0.0000166862,0.0003143308,0.00008833096,0.001165345],"category_scores_gemma":[0.00007336721,0.0001840814,0.00009710767,0.001131971,0.0005951209,0.0002731914,0.000169341,0.0004055378,0.000004165093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005316212,"about_ca_system_score_gemma":0.001127886,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01860972,"about_ca_topic_score_gemma":0.0006215135,"domain_scores_codex":[0.9961859,0.0006645887,0.000850139,0.0004339252,0.001145388,0.000720079],"domain_scores_gemma":[0.9972554,0.0006209273,0.0004066515,0.0003988504,0.001029136,0.0002890055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9292838,0.01864195,0.01022224,0.0001222936,0.001058635,0.000008149474,0.002260865,0.000004132104,0.001998302,0.00002092061,0.00193173,0.03444697],"study_design_scores_gemma":[0.9270204,0.004844456,0.06357855,0.0005267568,0.0003312286,0.00001248797,0.0000800334,0.00007615124,0.003204945,0.00001545639,0.000150245,0.0001592683],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986492,0.0004279234,0.000004871361,0.002923369,0.0001732767,0.006198028,0.002707005,0.000006958608,0.001066573],"genre_scores_gemma":[0.9966008,0.0003527982,0.0001488363,0.0001267589,0.0002734064,0.001474299,0.0001225687,0.00004763428,0.0008529134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05335632,"threshold_uncertainty_score":0.9997478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163301096","doi":"10.1186/bcr3100","title":"STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; University of California, Davis; National Cancer Institute; University of North Carolina at Chapel Hill; School of Medicine, New York University; York University; Fondazione Beretta; Ludwig Institute for Cancer Research; Susan G. Komen; Cancer Research Institute","keywords":"Surgical oncology; Breast cancer; Estrogen receptor; Estrogen; Medicine; Cancer research; Internal medicine; Oncology; Oestrogen receptor; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.06017544292289169,"gpt":0.371569569267839,"spread":0.3113941263449473,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007724587,0.0001898718,0.0002610027,0.0003023523,0.0002900847,0.00005685686,0.0001907195,0.00009124914,0.001570373],"category_scores_gemma":[0.00009508722,0.0001675021,0.0001015524,0.0007168889,0.000142033,0.0002082976,0.0001640434,0.0007109714,0.0004453151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001286893,"about_ca_system_score_gemma":0.001680077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003968755,"about_ca_topic_score_gemma":0.00007530934,"domain_scores_codex":[0.9973159,0.000185396,0.0002738505,0.0003691263,0.0008695278,0.000986233],"domain_scores_gemma":[0.9979007,0.0001654334,0.0000551415,0.0003330912,0.001026865,0.0005187216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00443215,0.001635191,0.08037793,0.0003073236,0.0004682388,0.0008244,0.007087801,0.00001304396,0.8047299,0.002852474,0.04369311,0.05357843],"study_design_scores_gemma":[0.002937554,0.001088817,0.4268276,0.001169756,0.0001893052,0.02292885,0.003292134,0.0001984609,0.2957597,0.00003114015,0.2446848,0.0008918802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869828,0.001799852,0.0001354217,0.003680231,0.0005372858,0.0005790362,0.0003703131,0.00007055616,0.005844479],"genre_scores_gemma":[0.9942139,0.00009497203,0.0007768811,0.0002019232,0.001367749,0.0001756713,0.00009267851,0.0000469804,0.003029225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5089702,"threshold_uncertainty_score":0.9993423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1851279030","doi":"10.1186/bcr1006","title":"The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Ligue Contre le Cancer; Cancer Care Ontario; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Association pour la Recherche sur le Cancer","keywords":"Ezrin; Surgical oncology; Cytoskeleton; Breast carcinoma; Metastasis; Breast cancer; Cancer research; Medicine; Oncology; Internal medicine; Chemistry; Cancer; Cell; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.07038864602877928,"gpt":0.3843165926465805,"spread":0.3139279466178012,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222197,0.0002251919,0.0004756897,0.0001925591,0.0004727973,0.00009950032,0.0003722368,0.000102574,0.0004833719],"category_scores_gemma":[0.00005893865,0.0001512658,0.0003375937,0.0005520179,0.0005768058,0.0001575163,0.0001680584,0.0003568175,0.00005804644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001635538,"about_ca_system_score_gemma":0.0006011831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008598542,"about_ca_topic_score_gemma":0.0001074831,"domain_scores_codex":[0.9967762,0.0001784739,0.0005318472,0.0005097581,0.001124931,0.0008787912],"domain_scores_gemma":[0.9973791,0.0004792479,0.0001176907,0.0007788313,0.0009359695,0.0003091538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.008519914,0.001613764,0.006911554,0.001175422,0.0005038895,0.0001031146,0.0005887874,0.00001110844,0.7603035,0.001136853,0.0651617,0.1539704],"study_design_scores_gemma":[0.01056095,0.00066395,0.08429182,0.0003074287,0.0002121058,0.001951382,0.0004838652,0.0007431409,0.78083,0.00007327321,0.1194933,0.0003888809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747965,0.001406861,0.00001175531,0.01974355,0.0001249278,0.001123798,0.001841161,0.00003384508,0.0009176121],"genre_scores_gemma":[0.9943487,0.0002259435,0.0002931968,0.0002104093,0.0006681398,0.0003338398,0.00001648966,0.00006623648,0.003837033],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1535815,"threshold_uncertainty_score":0.6168441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2129605756","doi":"10.1186/s13058-015-0647-3","title":"Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials","year":2015,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Physical Activity and Health","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Sex hormone-binding globulin; Randomized controlled trial; Meta-analysis; Psychological intervention; Confidence interval; Breast cancer; Observational study; Internal medicine; Strictly standardized mean difference; Subgroup analysis; Publication bias; Hormone; Cancer; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.3115122240669932,"gpt":0.5637674085684081,"spread":0.2522551845014149,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07573175,0.000511669,0.1188296,0.001273432,0.00003142493,0.00001453323,0.0002158668,0.0001944457,0.00008892021],"category_scores_gemma":[0.009756823,0.0002209099,0.008338762,0.002232061,0.0003258927,0.00004403326,0.00009798792,0.001016068,0.000004565374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005526821,"about_ca_system_score_gemma":0.001137063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007380726,"about_ca_topic_score_gemma":0.00001248402,"domain_scores_codex":[0.9543534,0.04073868,0.002108704,0.0005328846,0.001803124,0.0004632324],"domain_scores_gemma":[0.9588038,0.03780703,0.001910982,0.0007116986,0.0004605752,0.0003059517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.06368162,0.0007712923,5.633602e-8,0.7130823,0.2023013,0.000004169264,0.00007601342,4.376663e-7,0.000002052225,0.00002411848,0.00001974937,0.02003687],"study_design_scores_gemma":[0.05892133,0.0008649676,8.646588e-7,0.09710981,0.8427767,0.000005801006,0.000005610877,0.00006167618,0.000005435808,0.00001654732,0.00009821908,0.0001330961],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008620979,0.9727556,5.255458e-7,0.000405163,0.000007086061,0.02536908,0.0004766759,0.000007266657,0.0001165264],"genre_scores_gemma":[0.01706551,0.9636793,6.010754e-7,0.00002382192,0.0000657982,0.01892948,0.000009958442,0.00002954085,0.0001959655],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6404753,"threshold_uncertainty_score":0.9985844,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2042622775","doi":"10.1186/bcr2836","title":"Stress and breast cancer: from epidemiology to molecular biology","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Ottawa Hospital","funders":"","keywords":"Breast cancer; Epidemiology; Surgical oncology; Bioinformatics; Epidemiology of cancer; Medicine; Cancer; Biology; Physiology; Pathology; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1522603062808201,"gpt":0.4837635773093151,"spread":0.331503271028495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001571758,0.0008234244,0.004004182,0.0009900131,0.0002244123,0.00004178974,0.0007970407,0.0009674362,0.002476161],"category_scores_gemma":[0.0003023056,0.0006443266,0.0005624855,0.0009630216,0.0009551588,0.0000715368,0.0005892057,0.001841736,0.0002069435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009311027,"about_ca_system_score_gemma":0.003419979,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.08104765,"about_ca_topic_score_gemma":0.00115841,"domain_scores_codex":[0.992609,0.002402353,0.001079563,0.001717747,0.0004480373,0.001743341],"domain_scores_gemma":[0.9953634,0.001280365,0.000318349,0.001430165,0.0005983663,0.00100938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001474298,0.0001303541,0.00233888,0.006541579,0.0007450007,0.0001378348,0.0001166753,4.718526e-7,0.00002552819,0.0002422333,0.003715875,0.9845313],"study_design_scores_gemma":[0.0008346268,0.0002348394,0.009094629,0.02570722,0.0007469181,0.001446937,0.0000562183,0.000002540512,0.0000128422,0.0001367912,0.9611184,0.0006080231],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007973665,0.9863293,0.00002246816,0.003385373,0.0004579886,0.002041328,0.006541318,0.00007288467,0.0003520431],"genre_scores_gemma":[0.0002143768,0.9930037,0.0001058566,0.0004699515,0.002408767,0.002250785,0.0003142743,0.0001992256,0.001033025],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9839233,"threshold_uncertainty_score":0.9996008,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116236442","doi":"10.1186/bcr3484","title":"Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Sunnybrook Health Science Centre","funders":"American Society of Clinical Oncology; AstraZeneca","keywords":"Medicine; Olaparib; Neutropenia; Tolerability; Internal medicine; Febrile neutropenia; PARP inhibitor; Metastatic breast cancer; Taxane; Oncology; Breast cancer; Regimen; Cohort; Adverse effect; Surgery; Chemotherapy; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.08670294013995589,"gpt":0.4172623707952946,"spread":0.3305594306553387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004680478,0.0002823369,0.0007546447,0.0003152021,0.0001317487,0.00002527409,0.0001759416,0.00007912173,0.001847282],"category_scores_gemma":[0.00006236486,0.0001474844,0.0001177931,0.001122614,0.0005397858,0.0002581563,0.00003150386,0.0002397348,0.000002629036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001246494,"about_ca_system_score_gemma":0.001600855,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008433552,"about_ca_topic_score_gemma":0.008981326,"domain_scores_codex":[0.9969284,0.0003119821,0.0006443867,0.0004433843,0.00113739,0.000534483],"domain_scores_gemma":[0.9965805,0.0004627595,0.0003810321,0.0004603993,0.001941308,0.000173933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8393635,0.02355682,0.06043271,0.001068471,0.00122555,0.000007989133,0.003195232,0.000109398,0.001337723,0.0001156352,0.003002135,0.0665848],"study_design_scores_gemma":[0.7648706,0.0270954,0.1811973,0.001713242,0.0002567155,0.00002271012,0.0008077931,0.0005730874,0.02203709,0.0002869247,0.0008001727,0.0003388936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814954,0.000125155,0.00004035088,0.004160877,0.0001569359,0.009588486,0.004376137,0.00001341532,0.00004319186],"genre_scores_gemma":[0.9901115,0.000114267,0.0002288314,0.00006721752,0.0001613218,0.008483266,0.00008153657,0.00005593606,0.000696077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1207646,"threshold_uncertainty_score":0.9990652,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2974740020","doi":"10.1186/s13058-019-1194-0","title":"Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":175,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Beijing Key Laboratory of Green Recycling and Extraction of Metals; China Scholarship Council; China Sponsorship Council; Leids Universitair Medisch Centrum; Queen's University; Universiteit Leiden; Queen's University Belfast","keywords":"Breast cancer; Cancer research; Bone morphogenetic protein; Cancer; Epithelial–mesenchymal transition; Stromal cell; Biology; Medicine; Pathology; Metastasis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02457127677557405,"gpt":0.3699466645685853,"spread":0.3453753877930112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005374293,0.0003472925,0.0003282814,0.0001503408,0.0002963984,0.0001271013,0.0006912751,0.0003239705,0.002245853],"category_scores_gemma":[0.00007371257,0.0003086878,0.0001478537,0.0005079022,0.0002782659,0.00002103911,0.0004890368,0.00044796,0.0001075478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003467108,"about_ca_system_score_gemma":0.001793317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003107531,"about_ca_topic_score_gemma":0.001358719,"domain_scores_codex":[0.9961879,0.0003611516,0.0003452665,0.0009834034,0.0009922313,0.001130076],"domain_scores_gemma":[0.9977959,0.00004648995,0.0001665479,0.0006567655,0.0009737553,0.0003604771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001067452,0.0003391474,0.112884,0.0002231497,0.0002329456,0.000008331056,0.0001002688,0.0002387879,0.8519168,0.000004788619,0.006049155,0.02693513],"study_design_scores_gemma":[0.002744088,0.0003656421,0.4105291,0.002215856,0.00004822537,0.00004874687,0.0001387783,0.0003918688,0.5756125,0.00004021653,0.006993012,0.0008719228],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911766,0.003950482,0.000005195478,0.00181373,0.0002568967,0.001030129,0.001482939,0.00007469473,0.00020935],"genre_scores_gemma":[0.9949153,0.0004673377,0.00004699573,0.0001072553,0.0008082408,0.001030028,0.0001964304,0.0001124932,0.002315905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2976451,"threshold_uncertainty_score":0.9999365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167409131","doi":"10.1186/bcr1670","title":"An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":167,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Medical Research and Materiel Command; Deutsche Krebshilfe; National Cancer Institute; KWF Kankerbestrijding; Ministerstvo Školství, Mládeže a Tělovýchovy; National Breast Cancer Foundation; Huntsman Cancer Institute; Medical Research Council; Mayo Clinic; Cancer Care Ontario; Breast Cancer Research Foundation; University of Melbourne; Susan G. Komen; Helsingin ja Uudenmaan Sairaanhoitopiiri; National Health and Medical Research Council; Academy of Finland; Cancer Research UK; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Breast cancer; Medicine; Penetrance; Mutation; Cancer; Genetics; Oncology; Bioinformatics; Phenotype; Biology; Internal medicine; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.04140015731477487,"gpt":0.4089990854202221,"spread":0.3675989281054473,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001235347,0.0001466734,0.0002546862,0.0003744945,0.0000619608,0.00001623564,0.0003662303,0.000147155,0.00003015481],"category_scores_gemma":[0.000260548,0.0001360771,0.00004790509,0.0005372107,0.001244968,0.00002523867,0.0001596854,0.0002145875,1.642396e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001893416,"about_ca_system_score_gemma":0.0008813593,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01057808,"about_ca_topic_score_gemma":0.004549243,"domain_scores_codex":[0.9978935,0.0002682482,0.0005602505,0.0004274052,0.0005550098,0.0002956058],"domain_scores_gemma":[0.9981277,0.0001102073,0.0003131799,0.0003719047,0.00092452,0.0001524985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00102477,0.0001023749,0.4447838,0.0001958596,0.0004064002,0.000003758998,0.006999455,0.009484608,0.5094639,0.0001759761,0.0001535682,0.0272055],"study_design_scores_gemma":[0.0008925129,0.0001596727,0.6948633,0.00009960185,0.00003120318,0.000008855109,0.003562771,0.0005366022,0.2993988,0.0002608715,0.00007137496,0.0001143844],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959037,0.001869138,0.0003821741,0.0003015749,0.0001211577,0.0004868307,0.0008022797,0.000002450677,0.000130657],"genre_scores_gemma":[0.9981036,0.001168072,0.0004367708,0.00005872099,0.00007847147,0.00009407422,0.00002279324,0.0000237412,0.00001376155],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2500795,"threshold_uncertainty_score":0.9960105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095682369","doi":"10.1186/bcr3625","title":"A BRCA1deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute; National Institutes of Health; Avon Foundation for Women; U.S. Department of Defense","keywords":"Breast cancer; Gene signature; Cancer research; Brain metastasis; Medicine; Cancer; Oncology; Surgical oncology; Metastasis; Gene expression; Internal medicine; Pathology; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03162429040705599,"gpt":0.3528240869934397,"spread":0.3211997965863837,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002673321,0.0005407407,0.0008772918,0.0007427236,0.0003308022,0.0001466917,0.0001828784,0.0002824199,0.0007670153],"category_scores_gemma":[0.0001766227,0.0004399136,0.0001808152,0.001479876,0.0003886418,0.0002615874,0.0003296305,0.001193129,0.00002885258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006462223,"about_ca_system_score_gemma":0.0009905711,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02836552,"about_ca_topic_score_gemma":0.002720902,"domain_scores_codex":[0.9938293,0.001374179,0.0004946445,0.001250267,0.001631237,0.001420387],"domain_scores_gemma":[0.9969726,0.0007027903,0.0001340617,0.0008201476,0.0005114649,0.0008590017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.008328442,0.004113116,0.1372357,0.001322973,0.00134107,0.002365519,0.00298433,0.00003107572,0.4737967,0.0004699019,0.05115254,0.3168587],"study_design_scores_gemma":[0.0148637,0.0006919584,0.9471129,0.001246405,0.0003702975,0.001544558,0.0008830123,0.001737788,0.02498479,0.00007759182,0.005650268,0.0008366989],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9358177,0.00344557,0.00002551828,0.05546875,0.0002573593,0.001273558,0.003458782,0.0000848864,0.0001679259],"genre_scores_gemma":[0.9944211,0.0002308679,0.00009893799,0.003123789,0.0009620714,0.0003499793,0.0001220622,0.00009919925,0.0005919501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8098773,"threshold_uncertainty_score":0.9998053,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1559552676","doi":"10.1186/bcr934","title":"Ratios of involved nodes in early breast cancer","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saskatchewan Cancer Agency","funders":"Magyar Tudományos Akadémia","keywords":"Medicine; Breast cancer; Lymph node; Hazard ratio; Axillary Lymph Node Dissection; Odds ratio; Confidence interval; Epidemiology; Internal medicine; Lymph; Node (physics); Dissection (medical); Proportional hazards model; Surveillance, Epidemiology, and End Results; Oncology; Cancer; Surgery; Pathology; Cancer registry; Sentinel lymph node","retraction":null,"screen_n_in":null,"score":{"opus":0.03700942662397633,"gpt":0.360943594744124,"spread":0.3239341681201477,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003276456,0.0002192448,0.0002857321,0.0001948123,0.0001204269,0.00002691157,0.0003431969,0.0001443956,0.0001161049],"category_scores_gemma":[0.00002214699,0.0001994234,0.00009086294,0.0005609365,0.0003924383,0.00001537938,0.000256215,0.000238049,0.00001403639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003485729,"about_ca_system_score_gemma":0.0008244358,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0385328,"about_ca_topic_score_gemma":0.01572943,"domain_scores_codex":[0.9978906,0.0001198779,0.0002968226,0.0005436543,0.0005226774,0.000626388],"domain_scores_gemma":[0.998836,0.00002306902,0.00007612466,0.0004307109,0.0005126541,0.0001214725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00179877,0.000511987,0.8340783,0.0001364098,0.0002920456,0.00001955243,0.000711845,0.0007581703,0.1471492,0.0003310205,0.0007301948,0.01348256],"study_design_scores_gemma":[0.002726167,0.00007175338,0.9414922,0.0002362043,0.00001587164,0.00002759798,0.000274374,0.000003408965,0.05437424,0.0002243946,0.0003324605,0.0002213463],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916424,0.002800155,0.00002017632,0.003926616,0.00010764,0.0003660466,0.0007546696,0.00001292093,0.000369411],"genre_scores_gemma":[0.9971198,0.001536672,0.00008107057,0.0000935573,0.0003814149,0.0005716576,0.00003099024,0.0000421481,0.0001426646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1074139,"threshold_uncertainty_score":0.9678697,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118722680","doi":"10.1186/bcr2202","title":"Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":165,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Child and Family Research Institute; Institute for Research in Immunology and Cancer; University of British Columbia","funders":"National Cancer Institute; Terry Fox Foundation; Canadian Breast Cancer Research Alliance; Child and Family Research Institute","keywords":"Ribosomal s6 kinase; Kinase; Phosphorylation; Protein kinase B; Molecular biology; Biology; Cell biology; Cancer research; P70-S6 Kinase 1","retraction":null,"screen_n_in":null,"score":{"opus":0.0271952479613389,"gpt":0.3219428686493404,"spread":0.2947476206880015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003686574,0.0004485195,0.0005365536,0.0003552345,0.0002933573,0.00002730954,0.0005315513,0.0002460187,0.0008652437],"category_scores_gemma":[0.00001813312,0.0004147456,0.0001836272,0.0009382839,0.0006541677,0.0000334155,0.0005615418,0.000428459,0.00004005264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004327744,"about_ca_system_score_gemma":0.00104499,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0139218,"about_ca_topic_score_gemma":0.001678852,"domain_scores_codex":[0.9962108,0.0002247551,0.0004906749,0.001012651,0.0008736114,0.001187483],"domain_scores_gemma":[0.9982056,0.00003084026,0.0001568712,0.0007151724,0.0006208017,0.0002707057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002397344,0.0007605476,0.2109933,0.0002908745,0.0003707657,0.000163774,0.0003778976,0.0001038247,0.7728869,0.00001497367,0.006849146,0.004790655],"study_design_scores_gemma":[0.004057318,0.0002346168,0.2016346,0.0004977868,0.00003295069,0.0003010863,0.0003044812,0.00002202361,0.7870987,0.00002435391,0.005131396,0.0006606567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892666,0.00186357,0.000008093331,0.003169058,0.0001807891,0.0008926844,0.004145072,0.00002443169,0.0004497445],"genre_scores_gemma":[0.9939855,0.001886681,0.000257878,0.000144596,0.0005293794,0.001237211,0.00009360204,0.00008920844,0.001775895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01421176,"threshold_uncertainty_score":0.9998304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150910452","doi":"10.1186/bcr1828","title":"Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Women's College Hospital; Hôpital Saint-François d'Assise; University of Toronto; Université de Montréal; Hôtel-Dieu de Montréal; McGill University","funders":"Jewish General Hospital; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Surgical oncology; Breast cancer; Identification (biology); Medicine; Oncology; Cancer; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02268939394343911,"gpt":0.364076965689712,"spread":0.3413875717462729,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001771811,0.0001001509,0.0002007452,0.0009740843,0.00007823399,0.00002365,0.0001714584,0.0001211903,0.00008036529],"category_scores_gemma":[0.0001295746,0.0001111732,0.00004165892,0.002068195,0.0001131965,0.00001357434,0.00006094485,0.0001178218,0.000001116493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007969934,"about_ca_system_score_gemma":0.0008726875,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05272765,"about_ca_topic_score_gemma":0.1743989,"domain_scores_codex":[0.9983171,0.00008230496,0.0004321517,0.0003700844,0.0003571626,0.000441161],"domain_scores_gemma":[0.9982758,0.00004273847,0.0001396665,0.0002492685,0.001105304,0.0001872879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000275206,0.00007123958,0.3338526,0.00005424948,0.000302792,8.232939e-7,0.001401549,0.00266075,0.6379555,0.00004912891,0.00004616141,0.02332996],"study_design_scores_gemma":[0.0004985356,0.00003727631,0.9410329,0.0000457049,0.00004034916,0.000005099742,0.0003682814,0.001022937,0.05676539,0.0000127274,0.00006836395,0.0001024053],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946247,0.0004382806,0.0008974362,0.0005097209,0.00004954806,0.0003821496,0.003068564,0.000002599579,0.00002703843],"genre_scores_gemma":[0.9992712,0.000134714,0.00006177554,0.00003400777,0.00006505911,0.0002480349,0.0001055392,0.00001384522,0.00006588487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6071804,"threshold_uncertainty_score":0.9535803,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162584202","doi":"10.1186/bcr3462","title":"Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":157,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute","keywords":"Progesterone receptor; Breast cancer; Estrogen receptor; Medicine; Oncology; Internal medicine; Estrogen; Cancer; Biomarker; Surgical oncology; Tissue microarray; Cancer research; Gynecology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03499043794545057,"gpt":0.3461283579483459,"spread":0.3111379200028953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004975178,0.0005021957,0.0004609021,0.0001757084,0.0004785803,0.0001446056,0.0006175606,0.0002689444,0.004508314],"category_scores_gemma":[0.00007405024,0.0004466952,0.0001835135,0.0007122315,0.0006003508,0.00004253552,0.0006511112,0.0004664207,0.0008509121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005624457,"about_ca_system_score_gemma":0.0008215103,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03093214,"about_ca_topic_score_gemma":0.0005435076,"domain_scores_codex":[0.9953087,0.0003406556,0.000405109,0.001751693,0.0008802656,0.001313585],"domain_scores_gemma":[0.9963592,0.00006599732,0.0001649206,0.001185269,0.001826489,0.0003981835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003895658,0.0005799248,0.1174707,0.0001429137,0.001615425,0.000008563641,0.00110406,0.00001507011,0.5542606,0.0001322177,0.198237,0.1225379],"study_design_scores_gemma":[0.002612633,0.000324865,0.5271891,0.0003206545,0.00007757966,0.0001599812,0.0006449693,0.000010857,0.4528547,0.00009704684,0.0148327,0.0008749121],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9401031,0.005147909,0.000008520245,0.04617965,0.000448136,0.001606109,0.005728713,0.00006950022,0.0007084241],"genre_scores_gemma":[0.9850274,0.003577279,0.0004204076,0.00100401,0.002094463,0.003592576,0.0002260038,0.0001488632,0.003908971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4097184,"threshold_uncertainty_score":0.999927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030624081","doi":"10.1186/bcr3043","title":"Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Antimicrobial Peptides and Activities","field":"Immunology and Microbiology","cited_by":156,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute for Marine Biosciences; Dalhousie University","funders":"Natural Sciences and Engineering Research Council of Canada; Nova Scotia Health Research Foundation","keywords":"Surgical oncology; Medicine; Breast carcinoma; Cytolysis; Cancer research; Breast cancer; Mammary carcinoma; Oncology; Carcinoma; Internal medicine; Cytotoxicity; Cancer; Biology; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.04723724355409635,"gpt":0.2872505455515674,"spread":0.2400133019974711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004437196,0.0002365717,0.0004229555,0.0002512977,0.0003817965,0.00003253065,0.0003508646,0.0001435645,0.0001528761],"category_scores_gemma":[0.00001903963,0.0002166248,0.0001366667,0.0002380966,0.0008943666,0.0001780323,0.0002234343,0.000348897,0.00003825091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009319008,"about_ca_system_score_gemma":0.0003270909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005808561,"about_ca_topic_score_gemma":0.0002825358,"domain_scores_codex":[0.9981239,0.0002108625,0.0003515203,0.0004882,0.00009210178,0.0007333601],"domain_scores_gemma":[0.9987692,0.000149932,0.0001896803,0.0002800701,0.0005494864,0.00006168004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001275999,0.0008332201,0.01532563,0.0006150394,0.0001888898,0.000008626858,0.001079389,7.037299e-7,0.9613941,0.000528599,0.01699455,0.001755284],"study_design_scores_gemma":[0.003236178,0.0002660457,0.2461838,0.0004039431,0.00008333677,0.0004947187,0.001156046,0.000004936408,0.7471708,0.0002050483,0.0004198073,0.0003753586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950179,0.0008109313,0.00003318066,0.0003169785,0.0002877067,0.0007282809,0.002483778,0.00003211106,0.0002890925],"genre_scores_gemma":[0.9980734,0.0002186662,0.0001180293,0.00008139036,0.0001381019,0.0001129139,0.00003226244,0.00004501089,0.00118025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2308581,"threshold_uncertainty_score":0.8833704,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1860557886","doi":"10.1186/bcr573","title":"Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis","year":2003,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"National Cancer Institute","keywords":"Arteriogenesis; Angiogenesis; Immune system; Stromal cell; Neovascularization; Medicine; Breast cancer; Cancer research; Macrophage; Immunology; Inflammation; Tumor microenvironment; Cancer; Cancer cell; Inflammatory breast cancer; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03024285336477861,"gpt":0.3287566472290195,"spread":0.2985137938642409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009692346,0.0006124065,0.001072822,0.0005155552,0.0001539243,0.00007778873,0.0003713722,0.0005053559,0.0001992972],"category_scores_gemma":[0.000004301629,0.000564127,0.0001983612,0.0004695972,0.0003096617,0.00001145698,0.0005325279,0.000327146,0.00001357229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006185049,"about_ca_system_score_gemma":0.001296222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001149326,"about_ca_topic_score_gemma":0.001132722,"domain_scores_codex":[0.9961241,0.0004757812,0.0008002269,0.001201892,0.0004325277,0.0009654461],"domain_scores_gemma":[0.9989653,0.00003318879,0.0001913987,0.0004709352,0.00009153119,0.0002476742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001736803,0.0001840669,0.01470275,0.006333738,0.0003481433,0.00007129317,0.0001088928,0.000007335569,0.04360891,0.000003735225,0.0005759247,0.9338815],"study_design_scores_gemma":[0.0009211132,0.00004135478,0.1225643,0.006457245,0.0001153553,0.000312731,0.00009565825,0.000001521082,0.004819077,0.000001336102,0.8636121,0.001058164],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07034627,0.9278982,0.000001653023,0.0001065025,0.000112816,0.0008933141,0.0006008608,0.000004917312,0.00003548362],"genre_scores_gemma":[0.006057049,0.9912716,0.00006391098,0.00005121778,0.000229492,0.001753066,0.00006504627,0.0001300809,0.000378589],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9328234,"threshold_uncertainty_score":0.999681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164930765","doi":"10.1186/bcr1767","title":"Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre; Child and Family Research Institute; University of British Columbia","funders":"Sanofi","keywords":"Surgical oncology; Cancer research; Epidermal growth factor receptor; Breast cancer; Basal (medicine); Medicine; Human Epidermal Growth Factor Receptor 2; Cancer; Oncology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03539396611975684,"gpt":0.3233797551837885,"spread":0.2879857890640316,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007696176,0.0004087702,0.0003404793,0.0002099816,0.0005774092,0.0001110324,0.0003415497,0.0002192593,0.00009679687],"category_scores_gemma":[0.0000210986,0.0002912332,0.00009811176,0.0005396688,0.0003818072,0.00003454707,0.0001218651,0.0004199249,6.754907e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004021169,"about_ca_system_score_gemma":0.0007144912,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01251175,"about_ca_topic_score_gemma":0.004916492,"domain_scores_codex":[0.9967187,0.0002052597,0.0003595932,0.0009016822,0.0007079727,0.001106771],"domain_scores_gemma":[0.9987071,0.00006627398,0.0001269946,0.0002933039,0.0005916646,0.0002146308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007049026,0.000237763,0.02976458,0.0001145311,0.0003987276,0.000007472776,0.0008341142,0.000003669819,0.9458003,0.00002399783,0.00258678,0.01317905],"study_design_scores_gemma":[0.01222922,0.0008262859,0.1440571,0.0005059937,0.00004965649,0.0001582127,0.001495324,0.00002642016,0.8339261,0.0000618386,0.005645044,0.001018747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9660122,0.001754934,0.0001629748,0.02437595,0.0001071389,0.002232015,0.005309851,0.00002223008,0.00002266039],"genre_scores_gemma":[0.9952507,0.0006653506,0.0002074453,0.0005629643,0.0004778195,0.002237055,0.0002128658,0.0000932107,0.0002926071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1142925,"threshold_uncertainty_score":0.999954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141892812","doi":"10.1186/bcr3483","title":"Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; National Institutes of Health; Pennsylvania Department of Health; Susan G. Komen for the Cure","keywords":"Signal transduction; PI3K/AKT/mTOR pathway; Protein kinase B; Cell growth; Cell biology; Cancer research; Biology; MAPK/ERK pathway; Kinase; Chemistry; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01885206949620861,"gpt":0.2753162656027632,"spread":0.2564641961065546,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005952717,0.0003201166,0.0003506949,0.0001449261,0.0003083842,0.0001695684,0.0003138137,0.0002550483,0.0007349427],"category_scores_gemma":[0.00002081538,0.0002635559,0.00005848481,0.0004054037,0.0002795454,0.00003082911,0.0002277767,0.0003755261,0.00004143381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001457225,"about_ca_system_score_gemma":0.0008248863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002291346,"about_ca_topic_score_gemma":0.0005950265,"domain_scores_codex":[0.9972168,0.0002366383,0.00029864,0.000745584,0.0006328721,0.0008694257],"domain_scores_gemma":[0.9980041,0.00002751668,0.0001171924,0.0003881034,0.001111447,0.0003515884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003596971,0.0001202705,0.005476029,0.00007506077,0.0002334896,2.950886e-7,0.0002905231,0.00006663775,0.955057,0.000008665033,0.01707707,0.02123526],"study_design_scores_gemma":[0.003058496,0.0001095554,0.2388557,0.0003412957,0.00008771571,0.00003426088,0.0003804395,0.00006153678,0.4034078,0.00001571714,0.3527699,0.0008776583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886724,0.00811116,0.0000159058,0.0009325196,0.001173597,0.0006212599,0.0001861956,0.00002756745,0.0002594304],"genre_scores_gemma":[0.9863642,0.001925628,0.0001698159,0.0002520455,0.005269691,0.0005409443,0.0001240135,0.0000990288,0.005254594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5516493,"threshold_uncertainty_score":0.9999816,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1498382882","doi":"10.1186/bcr86","title":"Molecular biology of breast cancer metastasis Clinical implications of experimental studies on metastatic inefficiency","year":2000,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Ottawa Regional Cancer Foundation","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"Surgical oncology; Clinical significance; Breast cancer; Metastasis; Medicine; Lymph; Metastatic breast cancer; Oncology; Bone marrow; Cancer; Internal medicine; Pathology; Bioinformatics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.3442864368626668,"gpt":0.6022359423028764,"spread":0.2579495054402096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002002914,0.0006092964,0.004410598,0.001039975,0.0001233271,0.00001446808,0.0006326609,0.0002537447,0.001642004],"category_scores_gemma":[0.000116781,0.0004379069,0.0013704,0.002093595,0.0014935,0.00004910127,0.0003034803,0.001074743,0.00003199553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007271135,"about_ca_system_score_gemma":0.003629609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001902478,"about_ca_topic_score_gemma":0.00006740327,"domain_scores_codex":[0.9936018,0.001246845,0.002185066,0.001141849,0.0009932736,0.0008311921],"domain_scores_gemma":[0.9957204,0.0007223088,0.0007674458,0.001282256,0.001117769,0.0003898208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000462915,0.001553023,0.00008382698,0.01041767,0.003572062,0.00002105192,0.00009630341,0.00001050855,0.0003952687,0.0009362444,0.001072172,0.981379],"study_design_scores_gemma":[0.004871348,0.00248471,0.0006568579,0.04443505,0.0121165,0.001060852,0.0007677285,0.000006367633,0.004484275,0.0002173779,0.9275329,0.001366013],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00198927,0.9854317,0.000008294181,0.00093188,0.0002896483,0.00208526,0.008712206,0.00002342829,0.0005283471],"genre_scores_gemma":[0.01131969,0.9857826,0.0001890314,0.0000792237,0.0002976778,0.001923161,0.0001170836,0.000116032,0.0001754963],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.980013,"threshold_uncertainty_score":0.9998073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023064508","doi":"10.1186/bcr2930","title":"Male breast carcinoma: increased awareness needed","year":2011,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Breast Cancer Campaign","keywords":"Breast cancer; Medicine; Male breast cancer; Context (archaeology); Fulvestrant; Oncology; Epidemiology; Incidence (geometry); Aromatase; Surgical oncology; Breast carcinoma; Gynecology; Internal medicine; Cancer; Tamoxifen","retraction":null,"screen_n_in":null,"score":{"opus":0.2615901282581378,"gpt":0.4920495415055021,"spread":0.2304594132473643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00239845,0.001143469,0.004434991,0.001670273,0.0007180831,0.00008921227,0.001065839,0.000896763,0.007307057],"category_scores_gemma":[0.0001502138,0.0008957209,0.0008766617,0.002568349,0.0008428608,0.0001470272,0.001041273,0.003042758,0.001504363],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00216251,"about_ca_system_score_gemma":0.01254886,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.08176766,"about_ca_topic_score_gemma":0.0007251907,"domain_scores_codex":[0.9910058,0.001280451,0.001412864,0.001750645,0.001986384,0.002563861],"domain_scores_gemma":[0.9935275,0.0005140349,0.0004340107,0.002023962,0.001986946,0.001513561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007686817,0.0004695714,0.009514771,0.1083839,0.0004845556,0.0005973739,0.0001540291,2.891411e-8,8.782142e-7,0.0001531284,0.02286278,0.8566103],"study_design_scores_gemma":[0.001621422,0.0001327227,0.02698505,0.03308655,0.001165712,0.03239927,0.0001937922,0.000003460851,8.336155e-7,0.00001241808,0.9036338,0.0007649795],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004331903,0.9810029,0.000002111292,0.0009996357,0.0004783238,0.004162033,0.002473003,0.0001842308,0.01026461],"genre_scores_gemma":[0.001173937,0.9830996,0.00005468296,0.0001539886,0.002929025,0.003998877,0.0003445527,0.0003568977,0.007888401],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.880771,"threshold_uncertainty_score":0.9993494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2120004030","doi":"10.1186/bcr1608","title":"Gene expression signatures of morphologically normal breast tissue identify basal-like tumors","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Victoria General Hospital; Sunnybrook Health Science Centre; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Fondation du cancer du sein du Québec; McGill University","keywords":"Surgical oncology; Breast cancer; Gene expression; Biology; Pathology; Basal (medicine); Gene; Medicine; Cancer; Genetics; Internal medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.01972250675967603,"gpt":0.3394423429378802,"spread":0.3197198361782042,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004184006,0.0002887747,0.0003241483,0.0001584058,0.0002498736,0.00004153179,0.0005104436,0.0002345202,0.0004283525],"category_scores_gemma":[0.00002096367,0.0002395794,0.0001241877,0.0003656023,0.0004937145,0.00001467104,0.0005617745,0.0002926596,0.00002641186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001035119,"about_ca_system_score_gemma":0.0002430578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004005961,"about_ca_topic_score_gemma":0.00040247,"domain_scores_codex":[0.9971446,0.0002339384,0.0003660033,0.0007172014,0.0007932804,0.0007449199],"domain_scores_gemma":[0.9985042,0.00004175214,0.0001275793,0.0005671387,0.0006220583,0.0001373284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000835982,0.0003019676,0.02882029,0.00005451174,0.00007490834,0.00005042498,0.0000274936,0.0002335685,0.948654,0.00002895292,0.01617208,0.004745844],"study_design_scores_gemma":[0.0008028609,0.0001132378,0.5280735,0.00007437855,0.00001552704,0.0001298677,0.00004793772,0.000002660774,0.4692409,0.00009897137,0.001195888,0.0002042474],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925277,0.003550613,0.000120744,0.0009107037,0.0001817191,0.0004090553,0.001072098,0.00003078121,0.001196649],"genre_scores_gemma":[0.9969974,0.000219039,0.0003789423,0.00008462737,0.0008270332,0.0002586737,0.0002280906,0.00004972695,0.0009564648],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4992532,"threshold_uncertainty_score":0.9769763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1582325190","doi":"10.1186/bcr1503","title":"The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":135,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"The Quebec Population Health Research Network; Université Laval","funders":"National Cancer Institute; Hydro-Québec; Cancer Research Society","keywords":"Surgical oncology; Breast cancer; Matrix metalloproteinase; Medicine; Oncology; Internal medicine; Expression (computer science); Cancer; Cancer research; Bioinformatics; Biology; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.01544935202637868,"gpt":0.3220923103448639,"spread":0.3066429583184852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004581626,0.0001487891,0.0001286922,0.00005865207,0.0003066068,0.000052618,0.0002922422,0.0001372175,0.00004173234],"category_scores_gemma":[0.00002470148,0.0001016841,0.0000514362,0.0001839197,0.0002735944,0.00001083242,0.0002362763,0.0002225957,0.00000561583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004410879,"about_ca_system_score_gemma":0.0002298633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002474159,"about_ca_topic_score_gemma":0.000281526,"domain_scores_codex":[0.9982756,0.0001517093,0.0002009537,0.0004033628,0.0005105007,0.0004578794],"domain_scores_gemma":[0.9990109,0.00003130581,0.00007438017,0.0003656627,0.0004152842,0.0001025254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005593638,0.00008231094,0.007009831,0.00004391239,0.00001964109,0.000002249927,0.00001471103,0.0000873633,0.9753319,0.0001758179,0.00712454,0.009548384],"study_design_scores_gemma":[0.0004871467,0.0001560307,0.07579982,0.0002502872,0.000007039641,0.00002722746,0.00002713988,0.00001910958,0.91655,0.0002887924,0.006238872,0.0001484926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951105,0.00211736,0.000006873283,0.00155142,0.00006024131,0.0004295997,0.0002971659,0.000009443515,0.0004174662],"genre_scores_gemma":[0.9969985,0.00124771,0.00002317824,0.00007756454,0.0004739006,0.0004833641,0.0000133398,0.00002509072,0.0006573679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06878999,"threshold_uncertainty_score":0.4146557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098237452","doi":"10.1186/bcr3138","title":"Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","year":2012,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":133,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Université de Montréal; McGill University; University of Toronto; Canada Research Chairs; BC Cancer Agency; Women's College Hospital","funders":"National Cancer Institute; Cancer Care Ontario; National Institutes of Health; Cleveland Clinic","keywords":"Surgical oncology; Breast cancer; Medicine; Oncology; Breastfeeding; BRCA2 Protein; Mutation; Internal medicine; Gynecology; Cancer; Germline mutation; Genetics; Pathology; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.02027892552464059,"gpt":0.3465675483601522,"spread":0.3262886228355116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001629832,0.0001376584,0.0001786438,0.0001381984,0.0001727238,0.00003633418,0.0001745139,0.0001206623,0.0000860151],"category_scores_gemma":[0.00007733103,0.0001061611,0.00004108815,0.0003669642,0.0007940367,0.00002189028,0.0002050426,0.0002820501,0.000001122988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001877708,"about_ca_system_score_gemma":0.0003673583,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009451935,"about_ca_topic_score_gemma":0.001827408,"domain_scores_codex":[0.9982975,0.0003390512,0.0002252051,0.0003246201,0.0003460663,0.0004675403],"domain_scores_gemma":[0.9991398,0.00008607545,0.00009503886,0.0002609276,0.0002858059,0.0001323933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001764667,0.00007358337,0.7191356,0.0001524197,0.0003175258,0.000001850275,0.003797188,0.0005229627,0.05378032,0.0004882266,0.001137635,0.218828],"study_design_scores_gemma":[0.002353721,0.00002564284,0.9871077,0.0000778078,0.00004107662,0.0002153606,0.001301176,0.0003072371,0.007453205,0.000160536,0.0007920997,0.0001644492],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825467,0.01275363,0.00003610166,0.003274708,0.0001473246,0.0003674685,0.0005774572,0.000004941232,0.0002916542],"genre_scores_gemma":[0.9946511,0.004372839,0.00005562704,0.0000548372,0.0004507332,0.000278565,0.000009682301,0.00002727535,0.00009931073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2679721,"threshold_uncertainty_score":0.9971442,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103463982","doi":"10.1186/bcr1293","title":"Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2mutation carriers","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; McGill University; Ottawa Regional Cancer Foundation; Université du Québec; BC Cancer Agency; Women's College Hospital; University of Toronto","funders":"","keywords":"Surgical oncology; Breast cancer; Medicine; Oncology; Cancer; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02333667907452509,"gpt":0.3660553211140928,"spread":0.3427186420395677,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001119653,0.0001296538,0.0003371889,0.0003613444,0.00008025665,0.00002474638,0.00008949172,0.00008689131,0.0003597602],"category_scores_gemma":[0.00003741891,0.00008690896,0.00003172519,0.0005986136,0.0005768299,0.00009926448,0.00007873069,0.0005227708,0.000001318932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003952659,"about_ca_system_score_gemma":0.0003431645,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1104794,"about_ca_topic_score_gemma":0.1383058,"domain_scores_codex":[0.9983364,0.0002144345,0.0002315192,0.000316624,0.0004989917,0.0004019697],"domain_scores_gemma":[0.9992527,0.0001581475,0.00007126778,0.0002023242,0.0001724639,0.000143045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002597466,0.00005261779,0.8083166,0.0001293817,0.0000616859,0.000008551224,0.00314189,0.00003641747,0.001190973,0.000104006,0.0002787671,0.1840816],"study_design_scores_gemma":[0.005273629,0.00004188597,0.9900808,0.0003215107,0.00003618374,0.00006487279,0.0008058472,0.001439653,0.0004011155,0.00007449916,0.001368693,0.00009125101],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9680668,0.006620273,0.00000127344,0.02389939,0.0000506646,0.0006363263,0.0004581637,0.000007808235,0.0002593325],"genre_scores_gemma":[0.9784129,0.02071611,0.000009310807,0.0001059379,0.0003089746,0.0002281749,0.000003998288,0.00002076793,0.0001937832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1839904,"threshold_uncertainty_score":0.895444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1514900303","doi":"10.1186/bcr936","title":"Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview","year":2004,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Glucuronidation; Metabolic pathway; Enzyme; Chemistry; Breast cancer; Glucuronosyltransferase; Aromatase; Biochemistry; Metabolism; Glucuronic acid; Hydroxylation; Estrogen; Cancer; Biology; Internal medicine; Medicine; Endocrinology; Microsome","retraction":null,"screen_n_in":null,"score":{"opus":0.3416129515924802,"gpt":0.5837350972914798,"spread":0.2421221456989996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002921167,0.0008008186,0.00240289,0.001087196,0.000230624,0.00005544813,0.001283959,0.001005067,0.00333575],"category_scores_gemma":[0.00003400832,0.0007433051,0.000395615,0.002257719,0.0005093968,0.0002919954,0.0002288206,0.003284024,0.0001174716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005840141,"about_ca_system_score_gemma":0.003008239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002836358,"about_ca_topic_score_gemma":0.0001393085,"domain_scores_codex":[0.9913651,0.003806222,0.001363115,0.001101704,0.0009337154,0.001430148],"domain_scores_gemma":[0.9972588,0.0004370986,0.0003648047,0.0006902266,0.0005005053,0.0007485755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002162703,0.00127095,0.00007370691,0.01047316,0.0004653224,0.00004888953,0.0002517623,0.00005521697,0.004396926,0.001875219,0.0006332543,0.9802393],"study_design_scores_gemma":[0.001815775,0.00006480781,0.0001784309,0.003306686,0.0008365614,0.0002014175,0.00003768426,0.00002631585,0.006316688,0.0001641144,0.9864014,0.0006500538],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001824872,0.9856219,0.000009841914,0.0003395694,0.0005916286,0.002072055,0.009248226,0.00004452256,0.0002474339],"genre_scores_gemma":[0.005017176,0.9921515,0.0000270216,0.0001257987,0.000634569,0.001140393,0.0005544911,0.0001705569,0.0001784809],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9857682,"threshold_uncertainty_score":0.9995018,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965232244","doi":"10.1186/bcr2156","title":"Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; BC Cancer Agency; Child and Family Research Institute; University of British Columbia","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Biomarker; Proportional hazards model; Hazard ratio; Tissue microarray; Estrogen receptor; Surgical oncology; Cancer; Cohort; Disease; Confidence interval; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.06894104744754496,"gpt":0.3534857266464783,"spread":0.2845446791989333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005672763,0.0002919803,0.0003671992,0.000105321,0.0004201228,0.00007350895,0.0004428348,0.0001398222,0.0002255336],"category_scores_gemma":[0.0002533845,0.0002322015,0.0001503195,0.0002971569,0.0006227699,0.00002489495,0.0003305001,0.0003191441,0.000003360198],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001252731,"about_ca_system_score_gemma":0.001255015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00166556,"about_ca_topic_score_gemma":0.0004560061,"domain_scores_codex":[0.996628,0.0001924194,0.0003576046,0.0008238415,0.0008127946,0.001185307],"domain_scores_gemma":[0.9978211,0.0001720517,0.0001153918,0.0004977792,0.0006634379,0.0007302313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008945885,0.0001913058,0.7717284,0.0003090456,0.0002875154,0.00002718988,0.0004912184,0.0000162425,0.2061086,0.00002886341,0.00797229,0.003893407],"study_design_scores_gemma":[0.003760771,0.001058066,0.9443721,0.0004963565,0.00004759352,0.0001582009,0.001631481,0.0002147333,0.03109615,0.00002709189,0.01642487,0.0007126583],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853371,0.003348935,0.00002626665,0.001015548,0.0001212483,0.0009263015,0.009187154,0.00002019488,0.0000172073],"genre_scores_gemma":[0.9933057,0.003397572,0.0001081441,0.0000299278,0.0005109116,0.0004788808,0.0001691057,0.00008286315,0.001916937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1750125,"threshold_uncertainty_score":0.9468901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113865865","doi":"10.1186/s13058-014-0474-y","title":"Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia","year":2014,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":122,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Hospital; McMaster University Medical Centre; Canada Research Chairs; University Health Network; University of New Brunswick; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Universitätsklinikum Hamburg-Eppendorf; Instituto de Salud Carlos III; Cancer Council Victoria; Medical Research Council; Canadian Institutes of Health Research; School of Medicine; U.S. Department of Defense; Cancer Research UK; Universität Ulm; National Health and Medical Research Council; Universiti Malaya; Oulun Yliopisto; Deutsche Krebshilfe; Medizinischen Hochschule Hannover; Kuopion Yliopistollinen Sairaala; Karolinska Institutet; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Deutsche Gesetzliche Unfallversicherung; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Kommunfullmäktige, Stockholms Stad; Ministero della Salute; Academy of Finland; Robert Bosch Stiftung; Cancer Research Institute; Agency for Science, Technology and Research; National Breast Cancer Foundation; Cancer Center, University of Kansas; Cancerfonden; Fundación Mutua Madrileña; National Cancer Institute; Cancer Institute NSW; Breast Cancer Campaign; National Institute for Health and Care Research; KWF Kankerbestrijding; Peter MacCallum Cancer Centre; Herlev Hospital; National Institutes of Health; David F. and Margaret T. Grohne Family Foundation; University of Westminster; Deutsches Krebsforschungszentrum; Kansas Bioscience Authority; Sundhed og Sygdom, Det Frie Forskningsråd; Associazione Italiana per la Ricerca sul Cancro; Itä-Suomen Yliopisto; Helsingin ja Uudenmaan Sairaanhoitopiiri; Fox Chase Cancer Center; Eberhard Karls Universität Tübingen; Memorial Sloan-Kettering Cancer Center; Susan G. Komen for the Cure; Rheinische Friedrich-Wilhelms-Universität Bonn; Beth Israel Deaconess Medical Center; Royal Marsden NHS Foundation Trust; Huntsman Cancer Institute; Mayo Clinic; Breast Cancer Research Foundation","keywords":"Surgical oncology; Breast cancer; Medicine; Oncology; Internal medicine; Scale (ratio); Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01855494741682273,"gpt":0.3246105402506982,"spread":0.3060555928338755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007895226,0.000150831,0.0003415493,0.0001401652,0.0001382082,0.00002875101,0.0002080419,0.0001607314,0.0001915929],"category_scores_gemma":[0.0001394815,0.0001170268,0.0000762724,0.0004860612,0.0006789021,0.000008927342,0.0002163571,0.0001945626,5.77791e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001137407,"about_ca_system_score_gemma":0.0003646095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002537561,"about_ca_topic_score_gemma":0.002578913,"domain_scores_codex":[0.9980024,0.0003737222,0.000370821,0.0004957341,0.000405135,0.0003522123],"domain_scores_gemma":[0.9984921,0.0001527019,0.0001971962,0.0004387404,0.0006002102,0.0001190687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006718193,0.0001004604,0.8263734,0.00005645359,0.0006195633,0.0000012069,0.0009459209,0.00009919013,0.1520012,0.00006968553,0.0008513005,0.01820978],"study_design_scores_gemma":[0.0006630931,0.00008176474,0.9903064,0.00003717816,0.0003101951,0.000009854222,0.0003605326,0.001212298,0.003458717,0.00003526016,0.003400787,0.0001239713],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898087,0.001862751,0.000372089,0.00116365,0.00008722391,0.0002154158,0.006417251,0.000006672517,0.00006629535],"genre_scores_gemma":[0.9971745,0.001804992,0.0001519009,0.0001182191,0.0002245043,0.0001216444,0.0002904666,0.0000200803,0.00009367281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1639329,"threshold_uncertainty_score":0.4772214,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1539015594","doi":"10.1186/bcr1028","title":"Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Susan G. Komen; AstraZeneca","keywords":"Gefitinib; Surgical oncology; Cancer research; Breast cancer; Insulin-like growth factor; Epidermal growth factor receptor; Growth factor receptor inhibitor; Medicine; Oncology; Inhibitory postsynaptic potential; Internal medicine; Growth factor; Receptor; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.0377516380257656,"gpt":0.367743655658585,"spread":0.3299920176328194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001724167,0.0004066956,0.0009411853,0.001153281,0.0002229503,0.00006769335,0.0003417322,0.0003241562,0.001009766],"category_scores_gemma":[0.0001721346,0.0003787705,0.0001434189,0.001560305,0.001240541,0.0003785892,0.0003030481,0.001395615,0.00001838012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001247565,"about_ca_system_score_gemma":0.001624982,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01376169,"about_ca_topic_score_gemma":0.001061093,"domain_scores_codex":[0.9936764,0.0007343736,0.0009844234,0.0009356421,0.00243277,0.001236391],"domain_scores_gemma":[0.9963944,0.0006192892,0.0002781661,0.0004716779,0.001732244,0.0005042222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001297218,0.0006922429,0.03785966,0.006881805,0.0001045404,0.0000333097,0.001728583,0.0000173485,0.9274322,0.00008861977,0.001096651,0.02276781],"study_design_scores_gemma":[0.003822443,0.0004501429,0.1006613,0.006368666,0.00003647629,0.00003890786,0.0002484909,0.00005758414,0.887754,0.00007875515,0.0001619923,0.0003212302],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908513,0.004004293,0.000007700351,0.002008073,0.0002151004,0.002031925,0.0004762373,0.00004801421,0.0003572901],"genre_scores_gemma":[0.9944531,0.003064525,0.0001530577,0.00008305038,0.001082455,0.0007749615,0.00002391278,0.000108844,0.0002560336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06280163,"threshold_uncertainty_score":0.9999034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108739220","doi":"10.1186/bcr1042","title":"Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Government of Ontario; Cancer Research Society","keywords":"Surgical oncology; Connexin; Breast cancer; Gap junction; Medicine; Cancer research; Internal medicine; Biology; Cell biology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.02972297406830959,"gpt":0.3433389889307651,"spread":0.3136160148624555,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006761745,0.0001595653,0.0001701264,0.000130254,0.0001665913,0.00003679812,0.0004152818,0.0001825029,0.0009123355],"category_scores_gemma":[0.00004713438,0.0001393746,0.00006507834,0.0003123975,0.0002758538,0.00001136818,0.0002182996,0.0003748247,0.00009577404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001059343,"about_ca_system_score_gemma":0.0003113594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001383361,"about_ca_topic_score_gemma":0.005667802,"domain_scores_codex":[0.9981622,0.0003955787,0.000244763,0.0004385581,0.0002713423,0.0004875882],"domain_scores_gemma":[0.998987,0.00006146165,0.00006255478,0.0004274297,0.000339448,0.0001221402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001096212,0.0004308804,0.01943426,0.00004458494,0.00005342941,0.000006766647,0.000243544,0.00008018342,0.9363506,0.0002498141,0.01954712,0.02246253],"study_design_scores_gemma":[0.004576147,0.0004364269,0.2671255,0.0001718277,0.00002337698,0.0004107124,0.00147773,0.0005635486,0.1678461,0.0002070918,0.5561845,0.0009771007],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846885,0.004811166,0.00001499194,0.005403426,0.00007221646,0.0002983227,0.0003409798,0.00001694689,0.004353411],"genre_scores_gemma":[0.9948069,0.001870954,0.0001050642,0.00040198,0.0005279306,0.0002133781,0.0002843179,0.00002127069,0.001768191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7685046,"threshold_uncertainty_score":0.9989433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1798817938","doi":"10.1186/bcr1032","title":"Effects of milk fermented by Lactobacillus helveticusR389 on a murine breast cancer model","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Moncton","funders":"Consejo Nacional de Investigaciones Científicas y Técnicas; Université de Moncton","keywords":"Surgical oncology; Breast cancer; Lactobacillus; Fermentation; Food science; Medicine; Cancer; Microbiology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02820496031487803,"gpt":0.3096895162991594,"spread":0.2814845559842814,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003190602,0.0002121327,0.0002671567,0.00004636906,0.0002142442,0.00005233104,0.0004529224,0.0001346006,0.0007948354],"category_scores_gemma":[0.00001166753,0.00008977075,0.0001047346,0.0005981532,0.00017238,0.00009956205,0.0001831641,0.0003792582,0.00003947809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002767289,"about_ca_system_score_gemma":0.00006706603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002962696,"about_ca_topic_score_gemma":0.0008894874,"domain_scores_codex":[0.9976236,0.0001310127,0.0002495498,0.0004682846,0.0007840522,0.0007435226],"domain_scores_gemma":[0.9991381,0.0001235052,0.00007122562,0.000114619,0.0002975197,0.0002550562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006735373,0.0009605571,0.001075542,0.00007885519,0.00006474309,0.000004160754,0.0000596488,0.0002476515,0.8307377,0.000178173,0.008876427,0.157043],"study_design_scores_gemma":[0.005353956,0.001874234,0.4473631,0.001709622,0.0001066845,0.00008992681,0.0002238303,0.02010015,0.4960644,0.0005533912,0.02496018,0.001600503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821544,0.0009982566,0.00000312521,0.01331602,0.00006496785,0.0005596836,0.002141263,0.00004317137,0.0007190633],"genre_scores_gemma":[0.9967242,0.001130897,0.00001438062,0.0003032242,0.0003106115,0.0001730254,0.00003594096,0.000004393194,0.001303355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4462875,"threshold_uncertainty_score":0.8702891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152395868","doi":"10.1186/bcr3052","title":"Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2","year":2011,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Cancer Care Ontario; Université Laval; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec; St. Michael's Hospital","funders":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; National Cancer Institute; National Health and Medical Research Council; Canadian Institutes of Health Research; Cancer Center, University of Kansas; Fox Chase Cancer Center; ZonMw; Centre Léon Bérard; National Institutes of Health; Centre Hospitalier Universitaire de Nantes; Universiteit Leiden; Institut Claudius Regaud; Fondazione Italiana per la Ricerca sul Cancro; Radboud Universitair Medisch Centrum; Institut Bergonié; Deutsche Krebshilfe; Leids Universitair Medisch Centrum; Associazione Italiana per la Ricerca sul Cancro; Royal Marsden NHS Foundation Trust; Umeå Universitet; Istituto Oncologico Veneto; U.S. Public Health Service; Lietuvos Mokslo Taryba; Landspítali Háskólasjúkrahús; Lunds Universitet; Ministero della Salute; University of Pennsylvania; Institut Gustave-Roussy; Sahlgrenska Universitetssjukhuset; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; Huntsman Cancer Institute; Cancer Australia; National Breast Cancer Foundation; National Institute for Health and Care Research; Avon Foundation for Women; Universitair Medisch Centrum Groningen; Deutsches Krebsforschungszentrum; Linköpings Universitet; Alleanza Contro il Cancro; Canadian Breast Cancer Research Alliance; University of California, San Francisco; Creighton University; Helsingin ja Uudenmaan Sairaanhoitopiiri; Medical Research Council; Uppsala Universitet; Memorial Sloan-Kettering Cancer Center; Ohio State University; Radboud Universiteit; Kansas Bioscience Authority; Akademiska Sjukhuset; Cancer Care Ontario; KWF Kankerbestrijding; Cancer Research UK; Georgetown University; Breast Cancer Research Foundation","keywords":"Surgical oncology; Breast cancer; BRCA2 Protein; Allele; Medicine; Oncology; Mutation; Cancer research; Genetics; Cancer; Internal medicine; Biology; Germline mutation; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.05005496948432958,"gpt":0.3210897398061939,"spread":0.2710347703218643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001021316,0.0001680592,0.0003325694,0.0001084884,0.00007425454,0.00001123156,0.0003441156,0.0001749281,0.00004968898],"category_scores_gemma":[0.0002731033,0.0001319095,0.00005098648,0.0004909473,0.001509178,0.00001622004,0.00013832,0.0002580664,2.125999e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002159429,"about_ca_system_score_gemma":0.001250255,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0746925,"about_ca_topic_score_gemma":0.08909083,"domain_scores_codex":[0.9977311,0.0004917452,0.0005063235,0.0004816991,0.0004734679,0.00031563],"domain_scores_gemma":[0.9979062,0.0001615401,0.0004113113,0.0004860732,0.0009326626,0.0001022211],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003115175,0.0001718097,0.8807351,0.00009634651,0.0003722182,0.000004464916,0.0040698,0.0006553976,0.1078253,0.00004034204,0.0005779358,0.002336098],"study_design_scores_gemma":[0.001475636,0.0001092786,0.8272524,0.0002604605,0.00003363855,0.000006434807,0.003092617,0.000100874,0.1673745,0.0001566815,0.0000140406,0.0001235024],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922357,0.00140845,0.000005331635,0.0006095155,0.00004394809,0.0004089928,0.005159359,0.000005079372,0.0001236166],"genre_scores_gemma":[0.9992887,0.0003093776,0.00006336523,0.00003090726,0.00004958015,0.00008811115,0.0001212023,0.00002637595,0.00002237853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05954915,"threshold_uncertainty_score":0.9314692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2264885989","doi":"10.1186/s13058-016-0671-y","title":"Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2","year":2016,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Male Breast Health Studies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; European Regional Development Fund; National Health and Medical Research Council; Canadian Institutes of Health Research; lékařská fakulta Univerzity Karlovy; Fox Chase Cancer Center; National Institutes of Health; National Cancer Institute; Liga Portuguesa Contra o Cancro; Fondazione Italiana per la Ricerca sul Cancro; Leids Universitair Medisch Centrum; Lietuvos Mokslo Taryba; Ovarian Cancer Research Fund; Landspítali Háskólasjúkrahús; Istituto Toscano Tumori; Linköpings Universitet; Hungarian Scientific Research Fund; KWF Kankerbestrijding; Universitair Ziekenhuis Gent; Lunds Universitet; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Radboud Universitair Medisch Centrum; Norway Grants; Generalitat de Catalunya; Sahlgrenska Universitetssjukhuset; Beth Israel Deaconess Medical Center; Erasmus Medisch Centrum; Vrije Universiteit Amsterdam; National Breast Cancer Foundation; National Institute for Health and Care Research; David F. and Margaret T. Grohne Family Foundation; NIH Office of the Director; Ministério da Ciência, Tecnologia e Inovação; Universiteit Leiden; Breast Cancer Research Foundation; Univerzita Karlova v Praze; Deutsches Krebsforschungszentrum; Cancer Australia; Cancer Center, University of Kansas; Cancerfonden; Radboud Universiteit; Fundación Mutua Madrileña; Medical Research Council; Uppsala Universitet; Memorial Sloan-Kettering Cancer Center; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; University of California, San Francisco; Universiteit Gent; Institut Català de la Salut; University of Pennsylvania; Susan G. Komen for the Cure; Universitair Medisch Centrum Groningen; Istituto Oncologico Veneto; Umeå Universitet; Royal Marsden NHS Foundation Trust; European Social Fund; University of Chicago; Instituto de Salud Carlos III; Ohio State University; U.S. Department of Defense; Cancer Research UK; American Cancer Society; European Commission; Associazione Italiana per la Ricerca sul Cancro","keywords":"Surgical oncology; Breast cancer; Medicine; Oncology; Male breast cancer; BRCA2 Protein; Internal medicine; Cancer; Mutation; Pathology; Bioinformatics; Germline mutation; Genetics; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1208862515389755,"gpt":0.4213209062052272,"spread":0.3004346546662517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001607679,0.0001791768,0.0006489323,0.0002731434,0.00007511974,0.000005666432,0.0004493559,0.000144026,0.0006955363],"category_scores_gemma":[0.0004819397,0.0001124038,0.00004111591,0.0006227204,0.002451461,0.0001552757,0.0004658995,0.0003418524,0.000002783588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002308853,"about_ca_system_score_gemma":0.00182123,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07032001,"about_ca_topic_score_gemma":0.008102867,"domain_scores_codex":[0.9968989,0.0004811182,0.0007013396,0.0005724526,0.0008135245,0.0005325973],"domain_scores_gemma":[0.9969323,0.0007822759,0.0002946347,0.000963696,0.0007916227,0.0002354973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001542228,0.0001003713,0.9371367,0.0006870137,0.0001608081,0.00003802612,0.001726302,0.000007135323,0.01751708,0.0001979457,0.001681923,0.03920453],"study_design_scores_gemma":[0.002827707,0.00008467867,0.9908376,0.001376706,0.00006534684,0.000314366,0.001712437,0.0001567122,0.002188045,0.0001775831,0.0001570451,0.0001017422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665085,0.004905992,0.00001171415,0.01810383,0.0001050811,0.000751472,0.009403869,0.000009029479,0.0002004874],"genre_scores_gemma":[0.9971675,0.002180645,0.00006620755,0.0001201632,0.0001575182,0.0001273323,0.00002896955,0.00002779749,0.0001238282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06221714,"threshold_uncertainty_score":0.9358708,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133721908","doi":"10.1186/s13058-015-0540-0","title":"Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Statistics Canada; Ontario Institute for Cancer Research; CancerCare Manitoba; Mount Sinai Hospital; University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Ontario Institute for Cancer Research; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Susan G. Komen","keywords":"Metformin; AMPK; Medicine; Insulin receptor; Breast cancer; Protein kinase B; Internal medicine; Insulin; Endocrinology; PI3K/AKT/mTOR pathway; Cancer research; Cancer; Signal transduction; Oncology; Protein kinase A; Kinase; Insulin resistance; Biology; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0843348509387622,"gpt":0.3823107431341677,"spread":0.2979758921954055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002374858,0.0002693147,0.0004948254,0.0003522393,0.00007232569,0.00004430247,0.0004080884,0.0001985484,0.00021729],"category_scores_gemma":[0.000119084,0.0002515175,0.00006208957,0.0008279849,0.0001997767,0.00002888067,0.0002120519,0.0004657586,0.000004640276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004572518,"about_ca_system_score_gemma":0.002979651,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.009397305,"about_ca_topic_score_gemma":0.04068979,"domain_scores_codex":[0.996704,0.0005528412,0.0005028205,0.0006945642,0.0008304287,0.0007152781],"domain_scores_gemma":[0.9981929,0.00003373082,0.0001785827,0.0004430564,0.0007985095,0.0003532117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005943768,0.002174338,0.2900199,0.0001591935,0.0001951756,0.00004718477,0.002736028,0.0003583113,0.1001939,0.00006238955,0.0008503897,0.5972594],"study_design_scores_gemma":[0.02041484,0.003775564,0.5301824,0.00107337,0.0001006341,0.00009447971,0.02773459,0.0002545528,0.3974987,0.0005678617,0.01664389,0.001659134],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9705187,0.02661501,0.000005108503,0.0005572831,0.0001958017,0.001311997,0.000592739,0.00001038373,0.0001929712],"genre_scores_gemma":[0.9870802,0.01098524,0.00004172537,0.00007637949,0.000522131,0.001075328,0.0000684457,0.00004287153,0.000107694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5956002,"threshold_uncertainty_score":0.9999937,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1603850660","doi":"10.1186/bcr557","title":"Regulation of BRCA1 expression and its relationship to sporadic breast cancer","year":2002,"lang":"en","type":"review","venue":"Breast Cancer Research","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Surgical oncology; Cancer research; Medicine; Disease; Mutation; Gene; Gene expression; Cancer; Oncology; Biology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1092098742717286,"gpt":0.4255893334179934,"spread":0.3163794591462649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006851563,0.0003565388,0.0006785392,0.0004813669,0.0002147912,0.00004901913,0.0004659446,0.0005377594,0.0006561842],"category_scores_gemma":[0.00008733813,0.0003263426,0.0001740482,0.0009636233,0.0001686306,0.00001453561,0.0003753079,0.0004946997,0.00003766168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005613028,"about_ca_system_score_gemma":0.001336368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002736472,"about_ca_topic_score_gemma":0.0001110345,"domain_scores_codex":[0.9968669,0.0004320125,0.0005843035,0.0009109877,0.0006971926,0.0005086131],"domain_scores_gemma":[0.9979593,0.00008486916,0.0002670301,0.0007091859,0.0007273141,0.0002523405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001335679,0.00007724776,0.0004906064,0.006318203,0.0001620529,0.000002774731,0.0001292813,0.0001145142,0.005176629,0.000113227,0.01790503,0.9693769],"study_design_scores_gemma":[0.0004840644,0.00007563131,0.009906507,0.01082228,0.0001865419,0.0002652001,0.00003533613,0.00003154785,0.001153889,0.00004554375,0.9764016,0.0005918664],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001932053,0.9937423,0.0000224627,0.0005531967,0.0002129136,0.001214941,0.001954704,0.00001368375,0.0003537138],"genre_scores_gemma":[0.02947991,0.9649809,0.000118239,0.00002465531,0.0009457585,0.001152923,0.0002100551,0.0001104837,0.002977067],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.968785,"threshold_uncertainty_score":0.9999189,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2165477639","doi":"10.1186/bcr3573","title":"Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model","year":2013,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":117,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities; Zhejiang University; Barbara Ann Karmanos Cancer Institute; Cancerfonden; Fondation Leducq; York University; Cancer Genomics Centre","keywords":"Surgical oncology; Zebrafish; Breast cancer; Medicine; Metastasis; Oncology; Cancer research; Transforming growth factor; Cancer; Internal medicine; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0454522644183295,"gpt":0.3564692458019504,"spread":0.3110169813836209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005015581,0.0003362268,0.0003759202,0.0003016032,0.0003072405,0.0001881911,0.0006612872,0.000216619,0.0008933889],"category_scores_gemma":[0.00003184595,0.0003184684,0.0001897476,0.0004240841,0.0002533809,0.00004702865,0.000165798,0.0004777288,0.00002279362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002049043,"about_ca_system_score_gemma":0.0006945566,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01029361,"about_ca_topic_score_gemma":0.002330293,"domain_scores_codex":[0.9965905,0.0002457889,0.0004629481,0.0007860709,0.000767499,0.001147187],"domain_scores_gemma":[0.9983864,0.000047064,0.00008200975,0.000397456,0.0007165176,0.0003705255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003085759,0.0002375506,0.01512482,0.0001450209,0.000205042,0.000008305778,0.0002280623,0.002674455,0.9681919,0.00005506094,0.0008692876,0.01195189],"study_design_scores_gemma":[0.0091168,0.0003367451,0.152924,0.001185251,0.0001626165,0.0001093923,0.000815911,0.01035988,0.8192863,0.001280479,0.001949148,0.002473481],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993628,0.002429149,0.0006242338,0.001000746,0.00004425044,0.0009584878,0.001075958,0.00003853971,0.000200644],"genre_scores_gemma":[0.9970921,0.0002588845,0.0001096081,0.0001815364,0.0003829768,0.001570086,0.00007454902,0.00009054157,0.0002397652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1489056,"threshold_uncertainty_score":0.9999267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}